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  Cognitive dysfunction is a core and clinically-critical feature of schizophrenia. Certain 
cognitive deficits, such as impaired working memory, appear to emerge from altered gamma 
oscillations in the dorsolateral prefrontal cortex (DLPFC). Cortical gamma oscillations require 
the activity of parvalbumin (PV) interneurons and reduced PV interneuron activity in 
schizophrenia has been proposed to be due to deficient excitatory drive to these neurons. 
Synaptic pruning coincides with the period in which individuals with schizophrenia typically 
present their first clinical symptoms and thus an excessive pruning of excitatory inputs to PV 
interneurons in the DLPFC during development could provide the neural substrate for altered 
prefrontal gamma oscillations and working memory dysfunction in schizophrenia. However, 
evidence for pruning or pathogenic loss of excitatory inputs to PV interneurons in development 
and schizophrenia, respectively, and molecular mechanisms underlying these processes have not 
been identified. The formation of excitatory synapses on PV interneurons is mediated by ErbB4 
signaling pathway. ErbB4 transcript is alternatively spliced and each splice variant is associated 
with different functional effects. In schizophrenia, the total ErbB4 expression is unaltered, but 
alternative splicing of ErbB4 is dysregulated, suggesting that ErbB4 splicing shifts may provide 
molecular mechanisms for modulating the excitatory synapse number on PV interneurons. Using 
a top-down translational approach, I first characterized the association between dysregulated 
ErbB4 splicing shifts and fewer excitatory inputs to PV interneurons in a human cohort of 
comparison subjects and schizophrenia subjects. Then I assessed the developmental context of 
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this relationship in a cohort of non-human primates with different ages. Finally, I investigated the 
cause-and-effect relationship between ErbB4 splicing shifts and excitatory synapse number on 
PV interneurons using rat primary neuronal culture. Data from these different experimental 
systems converge onto the hypothesis that developmental shifts in ErbB4 splicing induce pruning 
of excitatory synapses on PV interneurons and deficits in this process result in a loss of 
excitatory inputs to PV interneurons in schizophrenia. Therefore, work from this dissertation 
reinforces the view that schizophrenia is a neurodevelopmental disorder with disturbances in the 
maturation of prefrontal cortical circuitry. 
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PREFACE 
 
“But small is the gate and narrow the road that leads to life, and only a few find it.” 
Matthew 7:14 
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improving the lives of those affected with psychiatric illnesses. 
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1.0  GENERAL INTRODUCTION 
Schizophrenia is a debilitating neuropsychiatric disorder that affects 0.5-1% of the 
world’s population (Lewis and Lieberman, 2000). Most affected individuals experience a 
lifetime of disability while 10% of patients eventually commit suicide (Lewis and Sweet, 2009). 
Thus, the average life expectancy of patients with schizophrenia is reduced by ~25 years (Saha et 
al., 2007) and as a result, schizophrenia is a leading cause of years of life lost to disability and 
premature mortality. Consequently, schizophrenia afflicts emotional burdens to families of those 
affected and incurs tremendous economic costs for society (Lopez and Disease Control Priorities 
Project., 2006). 
Etiology of schizophrenia is thought to require a complex and variable combination of 
genetic susceptibility and environmental risk factors that alter brain circuits which clinically 
manifest as a collection of symptoms and signs (Insel, 2010). Dysfunction of prefrontal cortical 
circuits is proposed to provide a key neural substrate for the pathophysiology underlying core 
clinical features of schizophrenia (Lewis et al., 2005). Clinical symptoms of schizophrenia 
usually appear in adolescence, during which the prefrontal cortical circuitry undergoes a process 
of massive refinement and maturation (Huttenlocher, 1979; Bourgeois et al., 1994; Rakic et al., 
1994). These observations led to a hypothesis that disturbances in the normal maturation process 
of prefrontal circuitry give rise to the core pathophysiology of schizophrenia (Weinberger, 1987; 
Lewis, 1997). In order to investigate such a hypothesis, it is crucial to identify components of 
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neural circuits that are affected in schizophrenia and characterize the normal developmental 
trajectory of those components. In the following sections, I will 1) review the core clinical 
feature and the associated prefrontal pathophysiology of schizophrenia, 2) introduce synaptic, 
molecular and transcriptional components of prefrontal cortical circuitry that might be disrupted 
in the illness, and 3) propose a model and testable hypotheses that could interlink the roles of 
these components in prefrontal cortical maturation and schizophrenia. 
1.1 COGNITIVE IMPAIRMENT AND ALTERED PREFRONTAL GAMMA 
OSCILLATIONS IN SCHIZOPHRENIA 
The core and clinically critical feature of schizophrenia constitutes cognitive impairments 
(Kahn and Keefe, 2013). First, poor cognitive performance, as measured by low IQ score or low 
scholastic achievement, is a robust risk factor for developing schizophrenia (MacCabe et al., 
2008; Khandaker et al., 2011). Second, decline in cognitive function begins in early puberty, 
years prior to the onset of psychosis (van Oel et al., 2002). Third, this decline does not 
necessarily stop once psychosis develops, but may gradually worsen over the disease progress 
(Hedman et al., 2013). Fourth, the time course of cognitive decline differentiates schizophrenia 
from bipolar disorder although both disorders are associated with psychotic symptoms 
(Reichenberg et al., 2002). Finally, cognitive impairment is the best predictor of long-term 
functional outcome for patients with schizophrenia (Bowie et al., 2006; Mohamed et al., 2008). 
Although such evidence supports the hypothesis that schizophrenia is a disorder of cognition, 
current pharmacological agents do not target etiopathogenic elements underlying cognitive 
dysfunction.  
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Certain cognitive features, such as working memory, that are affected in schizophrenia 
are thought to depend on the precisely timed transmission of information in cortical regions via 
synchronous oscillations at gamma band frequency (Uhlhaas and Singer, 2010; Senkowski and 
Gallinat, 2015). Numerous electroencephalography and magnetoencephalography studies have 
shown that the power of prefrontal gamma oscillations is reduced in patients with schizophrenia 
during cognitive tasks such as delayed discrimination task (Cho et al., 2006), Sternberg task 
(Chen et al., 2014) or oddball paradigms (Gallinat et al., 2004; Fujimoto et al., 2012). Thus, 
identifying pathogenic components of prefrontal cortical circuits underlying altered prefrontal 
gamma oscillations in schizophrenia is critical for the development of new therapeutic 
interventions for this illness. 
1.2 POTENTIAL COMPONENTS OF CORTICAL CIRCUITRY SUBSERVING 
ALTERTED PREFRONTAL GAMMA OSCILLATIONS IN SCHIZOPHRENIA 
1.2.1 Synaptic component: role of excitatory synaptic inputs to parvalbumin interneurons 
in generation of gamma oscillations 
The prefrontal neural network that generates gamma oscillations is proposed to involve 
pyramidal neurons and local GABAergic interneurons (Whittington et al., 2000). In this model, 
excitation from DLPFC pyramidal neurons recruits local interneurons, which in turn provide 
feedback inhibitory inputs to populations of asynchronously firing pyramidal neurons. Following 
the synaptic decay of the inhibitory transmission, the postsynaptic pyramidal cells subsequently 
fire in synchrony. A subset of interneurons that express the calcium binding protein parvalbumin 
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(PV) intrinsically provides inhibitory inputs at gamma frequency, generating a synchronous 
gamma oscillation in the pyramidal neuron network (Gonzalez-Burgos et al., 2015a). Thus, 
recruitment of PV interneurons by excitation from pyramidal neurons is critical in generating 
prefrontal gamma oscillations.  
A number of studies suggest that altered prefrontal gamma oscillations in schizophrenia 
may be due to deficits in excitatory synaptic inputs to PV interneurons. For example, abnormal 
gamma oscillations are observed in mouse models in which 1) glutamatergic receptor subunits, 
such as GluN1 or GluR1, are selectively knocked out in PV interneurons (Fuchs et al., 2007; 
Belforte et al., 2010), 2) signaling pathways that are involved in the formation of excitatory 
synapses on PV interneurons are disrupted (Del Pino et al., 2013; Pelkey et al., 2015) or 3) 
excitation of PV interneurons is optogenetically inhibited (Sohal et al., 2009). Consistent with 
these data, postmortem studies have repeatedly shown lower expression levels of activity-
dependent gene products (e.g., PV and the GABA-synthesizing enzyme glutamic acid 
decarboxylase 67, GAD67) in the DLPFC of schizophrenia, which are thought to reflect 
deficient excitatory drive to a subset of PV interneurons and not a loss of PV interneurons 
(Akbarian et al., 1995; Woo et al., 1997; Hashimoto et al., 2003; Enwright et al., 2016). These 
deficits do not seem to be caused by a global reduction in excitatory drive to all GABAergic 
interneurons, as calretinin-containing (CR) interneurons, the most abundant interneuron subtype 
in the primate DLPFC (Conde et al., 1994), are unaffected in schizophrenia (Hashimoto et al., 
2003; Fung et al., 2010). However, a pathological basis for deficient excitatory synaptic inputs to 
PV interneurons, such as fewer excitatory synapses on these neurons, has not been identified in 
the DLPFC of people with schizophrenia. 
 5 
1.2.2 Molecular component: role of ErbB4 signaling in formation of excitatory synapses 
on parvalbumin interneurons 
Formation and elimination of excitatory synapses on PV interneurons in the DLPFC 
could be, at least partly, modulated by ErbB4 signaling pathway. ErbB4 is a member of the ErbB 
transmembrane receptor tyrosine kinase family (Bublil and Yarden, 2007). Each ErbB protein 
has an extracellular region containing two extracellular cysteine-rich domains, a transmembrane 
domain, a short intracellular juxtamembrane region, a tyrosine kinase domain and a carboxyl-
terminal tail. In response to binding of its ligand neuregulins, ErbB proteins become dimerized to 
form homo- or heterodimers (Britsch, 2007). Among ErbB proteins, ErbB4 is the only 
autonomous NRG1-specific ErbB protein that can both interact with the ligand and become 
activated without forming heterodimers with other ErbB proteins. 
Activation of ErbB4 participates in various processes of neurodevelopment, including 
neuronal migration, axonal guidance, myelination, oligodendrocyte development, neuromuscular 
formation and synaptic plasticity (Mei and Xiong, 2008). More recently, ErbB4 has been shown 
to localize primarily in the cell bodies and the proximal dendrites of PV interneurons as well as 
CR interneurons (Vullhorst et al., 2009; Neddens et al., 2011) and participates in the 
development of GABAergic circuitry (Fazzari et al., 2010; Rico and Marin, 2011; Mei and Nave, 
2014). Importantly, the activation of ErbB4 signaling regulates the formation of excitatory 
synapses on PV interneurons, primarily by directly interacting with and stabilizing PSD95 at the 
synapse via its kinase motif and PDZ-binding motif (Huang et al., 2000; Ting et al., 2011; Del 
Pino et al., 2013; Seshadri et al., 2015). Therefore, a potential loss of excitatory synapses on PV 
interneurons in schizophrenia could be a result of abnormal ErbB4 signaling in these neurons. 
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However, evidence for disrupted ErbB4 signaling in PV interneurons has not been identified in 
the DLPFC of people with schizophrenia. 
1.2.3 Transcriptional component: role of alternative splicing in ErbB4 signaling 
Functional consequence of ErbB4 signaling can be modulated by alternative splicing. 
Alternative splicing of ErbB4 pre-mRNA results in four ErbB4 variants, each with different 
downstream signaling pathway (Veikkolainen et al., 2011). Splicing at the Juxtamembrane (JM) 
locus produces the minor JM-a and major JM-b variants based on the inclusion of exon 16 or 
exon 15b, respectively (Tan et al., 2010). Unlike the JM-b isoform, the inclusion of exon 16 
renders the JM-a isoform susceptible to proteolytic cleavage at the JM domain (Rio et al., 2000; 
Ni et al., 2001; Lee et al., 2002), generating soluble extracellular and intracellular truncated 
peptides, which could interfere with normal ErbB4 signaling. Furthermore, splicing at the 
Cytoplasmic (CYT) locus produces the minor CYT-1 and major CYT-2 variants based on the 
inclusion or exclusion of exon 26, respectively. Unlike the CYT-2 variant, the CYT-1 variant 
contains a binding site for Nedd4, an E3 ubiquitin ligase (Zeng et al., 2009). Binding of Nedd4 to 
CYT-1 results in an increased ubiquitination and a subsequent degradation of ErbB4, which 
could result in a loss of normal ErbB4 signaling. These findings suggest that a shift in alternative 
splicing from ErbB4 JM-b/CYT-2 to JM-a/CYT-1 variants could result in a loss of ErbB4 
signaling. 
 Consistent with the idea that ErbB4 signaling is disrupted in the illness, levels of ErbB4 
JM-a/CYT-1 variants are higher in the total gray matter DLPFC of schizophrenia (Silberberg et 
al., 2006; Law et al., 2007; Joshi et al., 2014). Moreover, the elevated ErbB4 splicing variants 
have been associated with the intronic SNPs at the ErbB4 locus that are linked to schizophrenia 
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(Law et al., 2007; Law et al., 2012). Finally, levels of myocardial infarction associated transcript 
(MIAT), a non-coding RNA that regulates the splicing of ErbB4 transcripts, are altered in 
schizophrenia (Barry et al., 2014). In concert, these findings suggest that a potential disruption in 
ErbB4 signaling in PV interneurons of schizophrenia could be due to an abnormal splicing of 
ErbB4 transcripts. However, evidence for dysregulated ErbB4 splicing in PV interneurons and 
its functional consequences has not been identified in the DLPFC of people with schizophrenia. 
1.2.4 Potential role of these components in prefrontal cortical maturation 
In humans and non-human primates, working memory performance and the associated 
DLPFC activity continue to improve through adolescence (Alexander, 1982; Goldman-Rakic, 
1987; Luna et al., 2010). During this period, excitatory synapses in the DLPFC undergo pruning 
(Huttenlocher, 1979; Bourgeois et al., 1994; Anderson et al., 1995; Petanjek et al., 2011), a 
maturation process that is thought to refine and strengthen functionally relevant synapses while 
eliminating weak or imprecise connections (Lichtman and Colman, 2000; Holtmaat and 
Svoboda, 2009). During gamma oscillations, PV interneurons require efficient detection of 
excitatory inputs with high precision and low variability, mainly due to the narrow time window 
of PV interneuron recruitment by pyramidal neurons (Jonas et al., 2004; Hu et al., 2014). 
Therefore, elimination of weak and imprecise excitatory synapses on PV interneurons could play 
a crucial role in the improvement of PV interneuron recruitment during gamma oscillations and 
consequently the maturation of working memory function through adolescence. Moreover, based 
on the idea that formation and elimination of excitatory synapses on PV interneurons may be 
modulated by ErbB4 signaling, a developmental shift in alternative splicing of ErbB4 transcripts 
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in PV interneurons could provide a molecular switch that regulates the pruning of excitatory 
synapses on these neurons. 
1.3 PROPOSED ROLE OF ERBB4 SPLICING IN PARVALBUMIN INTERNEURON 
MATURATION AND SCHIZOPHRENIA 
Based on these previous observations and ideas, I propose the following model that could 
interlink the role of ErbB4 splicing, ErbB4 signaling and excitatory synaptic input to PV 
interneurons in parvalbumin interneuron maturation and schizophrenia (Figure 1). In this model, 
alternative splicing of ErbB4 is developmentally shifted from the JM-b/CYT-2 to JM-a/CYT-1 
variants in PV interneurons through adolescence. This splicing shift results in a mild loss of 
ErbB4 signaling, which in turn induces an elimination of some of the excitatory synapses on PV 
interneurons. In schizophrenia, ErbB4 splicing shift is dysregulated and results in abnormally 
high levels of JM-a/CYT-1 variant and low levels of JM-b/CYT-2 variant. This abnormal 
splicing shift induces a pathogenic loss of ErbB4 signaling, which in turn induces an excessive 
loss of excitatory synapses on PV interneurons in schizophrenia.  
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Figure 1. Proposed role of ErbB4 splicing in parvalbumin interneuron maturation and schizophrenia. 
Developmentally shifts in ErbB4 splicing from the JM-b/CYT-2 to JM-a/CYT-1 variants in PV interneurons through 
adolescence results in a mild loss of ErbB4 signaling, which in turn induces an elimination of some of the excitatory 
synapses on PV interneurons. In schizophrenia, ErbB4 splicing shift is dysregulated and results in abnormally high 
levels of JM-a/CYT-1 variant and low levels of JM-b/CYT-2 variant. This abnormal splicing shift induces a 
pathogenic loss of ErbB4 signaling, which in turn induces an excessive loss of excitatory synapses on PV 
interneurons in schizophrenia. 
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In order to investigate the validity of this model, I have constructed three sets of specific 
hypotheses; subsequent chapters of this dissertation are dedicated to testing each of these 
hypotheses sets. In the first set of hypotheses (Chapter 2), I hypothesize that 1) in the DLPFC of 
schizophrenia, the levels of ErbB4 splicing variants are altered in PV but not in CR interneurons; 
2) dysregulated ErbB4 splicing in schizophrenia is associated with lower PV mRNA levels; and 
3) altered levels of MIAT and/or the schizophrenia-associated intronic SNPs at the ErbB4 locus 
predict dysregulated ErbB4 splicing in schizophrenia. In the second set of hypotheses (Chapter 
3), I hypothesize that 1) in the DLPFC of schizophrenia, lower PV levels reflect altered PV 
expression per neuron and not a loss of PV interneurons; 2) PV interneurons, but not CR 
interneurons, receive fewer excitatory synaptic inputs in schizophrenia; and 3) fewer excitatory 
synapses on PV interneurons are associated with dysregulated splicing of ErbB4 transcripts in 
schizophrenia. Finally, in the last set of hypotheses (Chapter 4), I hypothesize that 1) excitatory 
synapses on PV interneurons in monkey DLPFC undergo pruning during adolescence, 2) this 
developmental pruning is associated with shifts in alternative splicing of ErbB4 in PV 
interneurons, and 3) experimental manipulations of ErbB4 splice variants produce the predicted 
changes in excitatory inputs to PV interneurons. By testing these sets of hypotheses, the goal of 
this dissertation is to identify novel pathogenic elements in the prefrontal cortical circuitry 
associated with schizophrenia and characterize the role of these elements in the maturation of 
prefrontal cortical circuitry in order to further expand the understanding of pathogenic 
mechanisms subserving developmental disturbances in neural circuits affected in schizophrenia. 
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2.0  DYSREGULATED ERBB4 SPLICING IN SCHIZOPHRENIA: SELECTIVE 
EFFECTS ON PARVALBUMIN EXPRESSION 
Adapted from Chung DW, et al. (2016) Dysregulated ErbB4 Splicing in Schizophrenia: 
Selective Effects on Parvalbumin Expression. Am J Psychiatry 173(1):60-68. 
2.1 INTRODUCTION 
Neuregulin-1 and its receptor ErbB4 have been implicated in the pathogenesis of 
schizophrenia, and this association appears to involve dysregulated splicing of ErbB4 transcripts 
(Rico and Marin, 2011; Mei and Nave, 2014). For example, transcript levels of some ErbB4 
splicing variants are higher in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia 
subjects (Silberberg et al., 2006; Law et al., 2007; Joshi et al., 2014), whereas total ErbB4 
mRNA levels are unaltered (Silberberg et al., 2006; Law et al., 2007). Furthermore, the elevated 
ErbB4 splicing variants are associated with the intronic SNPs at the ErbB4 locus that are linked 
to schizophrenia (Law et al., 2007; Law et al., 2012). Finally, levels of myocardial infarction 
associated transcript (MIAT), a non-coding RNA that regulates the splicing of ErbB4 transcripts, 
are altered in schizophrenia (Barry et al., 2014). In concert, these findings support a role for 
dysregulated ErbB4 splicing in the pathogenesis of schizophrenia.  
 12 
Alternative splicing of ErbB4 pre-mRNA results in four ErbB4 variants, each with 
different functional effects (Veikkolainen et al., 2011). Splicing at the Juxtamembrane (JM) 
locus produces the minor JM-a and major JM-b variants based on the inclusion of exon 16 or 
exon 15b, respectively (Tan et al., 2010). The inclusion of exon 16 renders the JM-a isoform 
susceptible to proteolytic cleavage at the juxtamembrane domain (Rio et al., 2000; Ni et al., 
2001; Lee et al., 2002). Splicing at the Cytoplasmic (CYT) locus produces the minor CYT-1 and 
major CYT-2 variants based on the inclusion or exclusion of exon 26, respectively. Both the 
CYT-1 and CYT-2 isoforms couple to the MAPK signaling pathway, whereas only the CYT-1 
isoform activates the phosphoinositide 3-kinase (PI3-K)-Akt pathway (Junttila et al., 2000). 
Thus, although alternative splicing clearly influences ErbB4 signaling, the consequences of 
dysregulated ErbB4 splicing on DLPFC function in schizophrenia are unknown. 
In mouse prefrontal cortex, ErbB4 is preferentially expressed in parvalbumin (PV)-
positive interneurons (Fazzari et al., 2010) where it regulates the formation of excitatory inputs 
to, and hence the activity of, these cells (Ting et al., 2011; Del Pino et al., 2013). The activity of 
cortical PV interneurons is thought to be reduced in schizophrenia since the expression of two 
activity-dependent transcripts (Kinney et al., 2006; Belforte et al., 2010; Lau and Murthy, 2012), 
PV and glutamic acid decarboxylase (GAD67), are lower in PV interneurons in schizophrenia 
subjects (Hashimoto et al., 2003; Mellios et al., 2009; Fung et al., 2010; Volk et al., 2012b). 
Consistent with these findings, protein levels of PV and GAD67 are also lower in PV axon 
terminals in schizophrenia (Curley et al., 2011; Glausier et al., 2014). The idea that these 
alterations in PV neurons could be attributed to disturbed ErbB4 signaling is supported by 
findings that deletion of ErbB4 in PV interneurons in mice results in lower PV interneuron 
activity accompanied by lower PV and GAD67 levels (Del Pino et al., 2013).  
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Similar to mouse prefrontal cortex, ErbB4 is expressed in virtually all PV interneurons in 
primate DLPFC (Neddens et al., 2011). PV interneurons are heavily enriched in DLPFC layer 4 
and lower PV mRNA levels are restricted to DLPFC layers 3-4 in schizophrenia subjects 
(Hashimoto et al., 2003). ErbB4 is also expressed in all calretinin (CR)-positive interneurons, 
which are preferentially localized to primate DLPFC layer 2. Interestingly, CR mRNA levels are 
not altered in schizophrenia (Beasley et al., 2002; Hashimoto et al., 2003), suggesting that CR 
interneurons are relatively intact in the disease.  
Therefore, in this study, we sought to determine whether dysregulated ErbB4 splicing is 
associated selectively with PV interneurons, and not with CR interneurons, in schizophrenia. 
First, we hypothesized that in schizophrenia the levels of ErbB4 splicing variants are altered in 
DLPFC layer 4, where PV interneurons are heavily enriched, and not in DLPFC layer 2, where 
CR interneurons are highly localized. Second, we hypothesized that dysregulated ErbB4 splicing 
in schizophrenia is associated with lower PV mRNA levels in DLPFC layer 4. Finally, we 
hypothesized that the altered levels of MIAT and/or the schizophrenia-associated intronic SNPs 
at the ErbB4 locus contribute to dysregulated ErbB4 splicing in schizophrenia 
2.2 MATERIALS AND METHODS 
2.2.1 Human subjects 
Brain specimens were obtained during routine autopsies conducted at the Allegheny 
County Office of the Medical Examiner (Pittsburgh, PA) after consent was obtained from next-
of-kin. Consensus DSM-IV diagnoses for each subject were made by an independent team of 
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clinicians using structured interviews with family members and review of medical records (Volk 
et al., 2012b). The absence of a psychiatric diagnosis was confirmed in healthy comparison 
subjects using the same approach.  
To control for experimental variance and reduce biological variance, each subject with 
schizophrenia or schizoaffective disorder was matched with one healthy comparison subject for 
sex and as closely as possible for age. For the initial analysis of ErbB4 variant expression in gray 
matter, 62 pairs of subjects were used. For the layer-specific analysis of ErbB4 variant 
expression, a subset of these pairs (n=39) were used due to limitations in the availability of tissue 
sections for laser-microdissection (Appendix A; Table 3). The mean age, postmortem interval 
(PMI), RNA integrity number (RIN; Agilent Bioanalyzer, Agilent Technologies, Santa Clara, 
California), and tissue storage time did not differ between subject groups for either the 62 or 39 
subject pairs (Table 1). Although brain pH significantly differed between subject groups 
(t61=2.68, p=0.009 for 62 pairs; t38=3.12, p=0.003 for 39 pairs), the mean differences were very 
small (0.1 pH unit). Each subject had a RIN value ≥ 7.0, indicating an excellent quality of total 
RNA. 
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Table 1. Summary of demographic and postmortem characteristics of human subjects used in qPCR assays. 
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2.2.2 Total and layer-specific RNA extraction 
Tissue was collected from DLPFC area 9 and total RNA samples were prepared as 
described previously (Volk et al., 2012b). Fresh-frozen sections (12µm) from DLPFC area 9 
were mounted on microdissection slides (Leica Microsystems, Bannockburn, Illinois), fixed in 
ethanol/sodium acetate, stained in 0.5% thionin, and dehydrated with ethanol as previously 
described (Arion et al., 2015). The boundaries of layers 2 and 4 were determined based on the 
size and packing density of stained cells. A Leica microdissection system (LMD 6500, Leica 
Microsystems) was used to collect ~3X106 µm2 of tissue from each of layers 2 and 4 per subject 
from the same section. The collected tissue was lysed by vortexing for 30 seconds in 200μl of 
RLTplus buffer (Qiagen, Valencia, California). RNA was extracted using the RNeasy Plus Micro 
Kit (Qiagen) and complementary DNA (cDNA) was synthesized using the qScript cDNA 
SuperMix (Quanta Bioscience, Gaithersburg, Maryland) as previously described (Arion et al., 
2015). 
2.2.3 Quantitative PCR 
Primer sets were designed to quantify transcripts levels for parvalbumin, calretinin, four 
splicing variants of ErbB4 mRNA (JM-a, JM-b, CYT-1, CYT-2), pan-ErbB4 and MIAT 
(Appendix B; Table 4). All primer pairs showed amplification efficiency >98% in standard 
curve analyses and specific single products in dissociation curve analyses. The qPCR amplicons 
for each ErbB4 splicing variant yielded a single band of the predicted size on a gel (Appendix B; 
Figure 19) and were confirmed to span the alternative exons of ErbB4 transcripts (Appendix B; 
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Figure 20). The qPCR reactions were carried out in quadruplicate using an ABI StepOnePlus 
Real-Time PCR System (Applied Biosystem, Foster City, California). Beta-actin, glyceraldehyde 
3-phosphate dehydrogenase and cyclophilin A were used as reference genes to normalize the 
expression levels of transcripts, as these three house-keeping genes have stable levels of 
expression across both subject groups (Hashimoto et al., 2008a; Volk et al., 2014). The delta 
cycle thresholds (dCTs) were calculated for each sample using the geometric mean of the three 
endogenous reference genes as the normalizing factor. The expression level for each transcript 
was then calculated as the expression ratio value (expression ratio = 2-dCTs). 
2.2.4 Microarray analysis 
Microarray analysis of MIAT expression in Vicia villosa agglutinin (VVA)-positive PV 
interneurons was performed as previously described (see Appendix B; Supplementary 
Methods) (Georgiev et al., 2014). 
2.2.5 Genotype analysis 
DNA samples from the 62 subject pairs were genotyped as part of the CommonMind 
Consortium (http://commonmind.org/WP/) (see Appendix B; Supplementary Methods).  
2.2.6 Statistical analysis 
Two analyses of covariance (ANCOVA) models (paired and unpaired) were used to 
compare transcript levels in DLPFC gray matter, layer 2 or layer 4 between subject groups. The 
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paired ANCOVA model included mRNA level as the dependent variable; diagnosis as the main 
effect; subject pair as a blocking factor; and brain pH, RIN, PMI, and tissue storage time as 
covariates. This paired model accounts both for our attempts to balance diagnostic groups for sex 
and age and for the parallel tissue processing of both subjects in a pair, but is not a true statistical 
paired design. Therefore, we also used an unpaired ANCOVA model that included mRNA level 
as the dependent variable; diagnosis as the main effect; and sex, age, brain pH, RIN, PMI and 
storage time as covariates. Non-significant covariates were not included in the final analyses. 
Repeated measures models were also used to compare the levels of CR, PV, pan-ErbB4 and 
ErbB4 splicing variant mRNAs in layers 2 and 4 between subject groups (see Appendix B; 
Supplementary Methods).  
The paired and unpaired analyses from the ANCOVA and the repeated measures model 
produced comparable levels of statistical significance for the main effect of diagnosis on all 
transcript levels, except for JM-b levels in layer 2. The results from the paired ANCOVA 
analyses are reported in the main text and summarized in Appendix B, Table 5. For the repeated 
measures models only the main effect of layers on PV or CR mRNA levels within subjects are 
reported in the main text with the remaining outcomes summarized in Appendix B, Table 5. The 
potential influence of co-morbid factors on the layer-specific levels of ErbB4 splicing variants in 
schizophrenia subjects were assessed as previously described (Volk et al., 2012b) (see Appendix 
B; Supplementary Methods). Pearson’s correlation analyses were performed to assess the 
layer-specific association among the ErbB4 splicing variants and PV or CR levels (see 
Appendix B; Supplementary Methods). In the microarray analysis, normalized and log2-
transformed signals of MIAT were compared between subject groups using paired t test as 
previously described (Georgiev et al., 2014). In the genotype analyses, analyses of variance 
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models were used to test the main effect of genotypes on the ratios of JM-a/JM-b variants and 
CYT-1/CYT-2 variants in total gray matter of 62 subject pairs or layer 4 of 39 subject pairs. 
2.3 RESULTS 
2.3.1  ErbB4 splicing is dysregulated in DLPFC of subjects with schizophrenia 
In DLPFC gray matter homogenates from the 62 pairs of schizophrenia and healthy 
comparison subjects, mean pan-ErbB4 mRNA levels did not differ between subject groups 
(Figure 2A). Consequently, we normalized the levels of ErbB4 splicing variants to the pan-
ErbB4 levels within each subject to reduce the variability in ErbB4 splicing variant levels 
attributable to between-subject differences in total ErbB4 expression. Mean normalized JM-a 
mRNA levels were significantly (F1,61=7.49; p=0.008) 10.9% higher and mean normalized JM-b 
mRNA levels were significantly (F1,61=17.1; p<0.001) 11.5% lower in schizophrenia subjects 
relative to healthy comparison subjects (Figure 2B). Although mean normalized CYT-1 mRNA 
levels did not differ between subject groups, mean normalized CYT-2 mRNA levels were 
significantly (F1,60=12.3; p<0.001) 10.0% lower in schizophrenia subjects (Figure 2C). None of 
the covariates were significant in any of these analyses except for an effect of RIN on CYT-2 
mRNA levels (F1,60=5.02, p=0.029).  
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Figure 2. mRNA levels for pan-ErbB4 and normalized ErbB4 splicing variants in DLPFC area 9 total gray matter for each matched pair of healthy 
comparison and schizophrenia subjects. 
Markers to the right or left of the diagonal unity line indicate lower or higher mRNA levels in schizophrenia subjects, respectively. (A) Mean (±SD) 
mRNA levels for pan-ErbB4 mRNA levels did not differ between schizophrenia (0.041±0.006) and comparison subjects (0.040±0.005). (B) Mean mRNA 
levels were statistically significantly higher for JM-a and lower for JM-b in schizophrenia (JM-a: 0.133±0.04, JM-b: 0.500±0.12) relative to comparison 
subjects (JM-a: 0.120±0.03, JM-b: 0.565±0.09). (C) CYT-1 mRNA levels did not differ whereas CYT-2 mRNA levels were lower in schizophrenia 
(CYT-1: 0.103±0.03, CYT-2: 0.304±0.06) relative to comparison subjects (CYT-1: 0.098±0.02, CYT-2: 0.338±0.05).  
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2.3.2 Micro-dissection of layer 2 or 4 yields samples enriched in CR or PV interneurons, 
respectively 
Next, we quantified CR and PV mRNA levels in micro-dissected samples of cortical 
layers 2 and 4 from the 39 matched pairs of schizophrenia and comparison subjects (Figure 3A, 
B). Relative to layer 4, CR mRNA levels in layer 2 were significantly 9.4 and 9.8 fold higher, 
respectively, in healthy comparison (Repeated Measures: F1,114=593; p<0.001) and in 
schizophrenia (Repeated Measures: F1,114=517; p<0.001) subjects. Relative to layer 2, PV 
mRNA levels in layer 4 were significantly 13.9 and 10.9 fold higher, respectively, in healthy 
comparison (Repeated Measures: F1,114=590; p<0.001) and in schizophrenia (Repeated 
Measures: F1,114=373; p<0.001) subjects. These data confirm that layer 2 is largely devoid of PV 
interneurons and heavily enriched in CR interneurons, whereas the opposite is true for layer 4. 
Mean CR mRNA levels did not differ in either layer 2 or 4 between subject groups (Figure 3C, 
D). In contrast, mean PV mRNA levels were significantly (F1,38=14.6; p<0.001) 19.5% lower in 
layer 4 of schizophrenia subjects but did not differ in layer 2 between subject groups (Figure 3C, 
D). In concert, these findings are consistent with a prior report that in the DLFPC of 
schizophrenia subjects PV expression is selectively altered in layer 4 but not in layer 2, whereas 
CR expression is not altered in any layer (Hashimoto et al., 2003). 
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Figure 3. Layer-specific quantification of PV and CR mRNA levels in DLPFC area 9 for each matched pair of 
healthy comparison and schizophrenia subjects. 
(A) Based on the size and packing density of Nissl-stained cells, layers 2 and 4 were identified and laser micro-
dissected from the same section. (B) In layer 2, CR mRNA was heavily expressed relative to PV mRNA and CR 
mRNA levels did not differ between schizophrenia (CR: 0.065±0.02, PV: 0.007±0.003) and comparison subjects 
(CR: 0.069±0.02, PV: 0.007±0.003). (C) In layer 4, PV mRNA was heavily expressed relative to CR mRNA and PV 
mRNA levels were significantly lower in schizophrenia (CR: 0.006±0.002, PV: 0.065±0.02) relative to comparison 
subjects (CR: 0.006±0.003, PV: 0.080±0.02).  
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2.3.3 Abnormal shifts in ErbB4 splicing from major to minor variants occur selectively in 
DLPFC layer 4 of schizophrenia subjects 
Mean pan-ErbB4 mRNA levels did not differ in either layer 2 or layer 4 between subject 
groups (Figure 4A, D). Mean normalized JM-a mRNA levels were significantly (F1,38=4.62, 
p=0.038) 22.1% higher, whereas mean normalized JM-b mRNA levels were significantly 
(F1,38=15.1, p<0.001) 17.0% lower in layer 4 of schizophrenia subjects (Figure 4E). Neither 
transcript level was significantly different between subject groups in layer 2 (Figure 4B). Mean 
normalized CYT-1 mRNA levels were significantly (F1,38=7.07, p=0.011) 19.3% higher, whereas 
mean normalized CYT-2 mRNA levels were nearly significantly (F1,38=3.98, p=0.053) 10.2% 
lower in layer 4 of schizophrenia subjects (Figure 4F). Neither transcript level was significantly 
different between subject groups in layer 2 (Figure 4C). None of the covariates were significant 
in any of these analyses except for an effect of brain pH on JM-b mRNA levels in layer 2 
(F1,37=8.34, p=0.006). In addition, mean normalized levels of JM-a, JM-b, CYT-1 and CYT-2 
mRNAs in layer 4 of schizophrenia subjects did not differ significantly as a function of sex, 
diagnosis of schizoaffective disorder, history of substance dependence or abuse, nicotine use at 
the time of death, use of antipsychotics, antidepressants, or benzodiazepines and/or sodium 
valproate at the time of death, or death by suicide (Appendix B; Figure 21).  
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Figure 4. Layer-specific quantification of mRNA levels for pan-ErbB4 and normalized ErbB4 splicing variants 
(A, D) In layers 2 and 4, mean (±SD) pan-ErbB4 mRNA levels did not differ between schizophrenia (layer 2: 0.045±0.01, layer 4: 0.042±0.01) and comparison 
subjects (layer 2: 0.045±0.01, layer 4: 0.045±0.02). (B, C) In layer 2, JM-b levels were lower whereas CYT-1, CYT-2 and JM-a levels did not differ between 
schizophrenia (JM-a: 0.144±0.04, JM-b: 0.515±0.13, CYT-1: 0.119±0.05, CYT-2: 0.240±0.12) and healthy comparison subjects (JM-a: 0.131±0.05, JM-b: 
0.606±0.13, CYT-1: 0.121±0.04, CYT-2: 0.248±0.11). (E, F) In layer 4, CYT-1 and JM-a levels were higher, JM-b levels were lower and CYT-2 levels did not 
differ in schizophrenia subjects (JM-a: 0.157±0.07, JM-b: 0.471±0.13, CYT-1: 0.127±0.05, CYT-2: 0.217±0.11) relative to healthy comparison subjects (JM-a: 
0.129±0.05, JM-b: 0.567±0.14, CYT-1: 0.107±0.03, CYT-2: 0.242±0.13). 
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2.3.4 PV mRNA levels are negatively correlated with the ratio of JM-a/JM-b variants in 
DLPFC layer 4 of schizophrenia subjects 
In layer 2, CR mRNA levels did not correlate with the ratio of either JM-a/JM-b variants 
or CYT-1/CYT-2 variants in either schizophrenia or healthy comparison subjects. In layer 4, a 
strong negative correlation was observed between PV mRNA levels and the ratio of JM-a/JM-b 
variants only in schizophrenia subjects (r=-0.50; p<0.001). The ratio of CYT-1/CYT-2 variants 
did not correlate with PV mRNA levels in layer 4 of either subject group (Appendix B; Table 
6).  
2.3.5 MIAT levels are increased preferentially in PV interneurons in schizophrenia 
subjects 
Next we assessed whether abnormal MIAT levels might contribute to dysregulated 
ErbB4 splicing in schizophrenia. In DLPFC gray matter homogenates from the 62 subject pairs, 
mean MIAT levels were significantly (F1,60=6.79, p=0.012) 12.6% higher in schizophrenia 
subjects relative to healthy comparison subjects (Figure 5A). None of the covariates were 
significant except for an effect of RIN (F1,60=4.08, p=0.048). In DLPFC gray matter, the levels of 
MIAT were significantly positively correlated with the ratio of JM-a/JM-b variants (r=0.26; 
p=0.004) and the ratio of CYT-1/CYT-2 variants (r=0.21; p=0.021) and significantly negatively 
correlated with PV mRNA levels (r=-0.20; p=0.027) across all subjects. MIAT is expressed not 
only in layers 2 and 4, but is also found in high levels in layers 3 and 5 (Hawrylycz et al., 2012), 
suggesting that MIAT may be expressed in both pyramidal cells and interneurons in DLPFC 
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layer 4. Thus, in order to assess MIAT levels selectively in PV interneurons, we evaluated MIAT 
levels in laser-microdissected cells labeled with the PV-specific marker Vicia villosa agglutinin 
(VVA) from available microarray data in 14 of our subject pairs (Appendix A; Table 3) 
(Georgiev et al., 2014). Mean MIAT levels were significantly (t13=-3.17, p=0.007) 50.8% higher 
in VVA-positive cells in subjects with schizophrenia relative to healthy comparison subjects 
(Figure 5B). In the DLPFC gray matter of these 14 subject pairs, mean MIAT levels did not 
differ (F1,13=0.17, p=0.690) between subject groups (Figure 5A) suggesting that increased MIAT 
expression preferentially occurs in PV neurons.  
 
Figure 5. Quantification of MIAT levels in DLPFC area 9 total gray matter for 62 subject pairs and in Vicia 
villosa agglutinin (VVA)-positive cells for 14 subject pairs. 
(A, B) Mean MIAT levels were significantly higher in DLPFC total gray matter and in VVA-positive cells of 
schizophrenia (total gray matter: 0.045±0.01, VVA (log2 value): 6.059±0.56) relative to healthy comparison subjects 
(total gray matter: 0.040±0.01, VVA (log2 value): 6.652±061). 
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2.3.6 Schizophrenia-associated intronic SNPs at the ErbB4 locus are not associated with 
the ratios of ErbB4 splicing variants 
Finally, we investigated the effect of schizophrenia-associated intronic SNPs at the 
ErbB4 locus on the ratios of ErbB4 splicing variants in DLPFC total gray matter of 62 subject 
pairs or in DLPFC layer 4 of 39 subject pairs. The risk SNP at rs4673620 was previously 
implicated with higher JM-a mRNA levels, whereas the risk SNPs at rs7598440, rs707284 and 
rs839523 were associated with higher CYT-1 mRNA levels in schizophrenia subjects (Law et 
al., 2007). Our SNP analyses did not reveal a main effect of rs4673620 on the ratio of JM-a/JM-b 
variants in total gray matter or in layer 4 of all subjects. No main effect of rs7598440, rs707284 
or rs839523 on the ratio of CYT-1/CYT-2 variants in either total gray matter or in layer 4 was 
observed in all subjects. Interactions between diagnosis and genotypes were also not detected in 
either total gray matter or layer 4 of all subjects (Appendix B; Table 7). 
2.4 DISCUSSION 
Dysregulated alternative splicing of ErbB4 mRNAs has been consistently observed in the 
DLPFC of schizophrenia subjects (Silberberg et al., 2006; Law et al., 2007; Law et al., 2012; 
Joshi et al., 2014). Higher JM-a variant and unaltered pan-ErbB4 levels in schizophrenia subjects 
have been replicated in all prior studies and were also confirmed in the present study. In contrast 
to prior studies, we also detected the expected lower levels of JM-b mRNA in schizophrenia 
subjects. Reciprocal differences in the levels of JM variants, accompanied by unchanged pan-
ErbB4 mRNA levels, argue for an abnormal shift in ErbB4 splicing from JM-b to JM-a variants 
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in schizophrenia. Three previous reports showed higher CYT-1 variant levels in the DLPFC of 
schizophrenia subjects (Silberberg et al., 2006; Law et al., 2007; Law et al., 2012), whereas the 
most recent study found no change (Joshi et al., 2014). We found unaltered CYT-1 variant levels 
but did detect lower levels of CYT-2 variants in schizophrenia subjects. In concert, these 
findings suggest that a modest shift in splicing from CYT-2 to CYT-1 variants may occur in 
some subjects with schizophrenia. 
Next, we sought to investigate whether dysregulated ErbB4 splicing is associated 
selectively with PV interneurons and contributes to lower PV mRNA levels in schizophrenia.  
The laminar micro-dissection yielded preferential enrichment of CR or PV mRNA in layer 2 or 
4, respectively, and comparable levels of pan-ErbB4 in both layers. Because ErbB4 is localized 
in CR and PV interneurons in the primate DLPFC (Neddens et al., 2011), our results support the 
idea that the layer-specific quantification of ErbB4 mRNAs allows an indirect measurement of 
their levels in each of those cell types. Pan-ErbB4 mRNA levels were unaltered in either layer 2 
or 4 of schizophrenia subjects, suggesting that transcription of the ErbB4 gene is not affected in 
either CR or PV interneurons in schizophrenia. We found significantly higher levels of JM-a and 
CYT-1 variants and significantly lower levels of JM-b variants and nearly significantly lower 
CYT-2 variant levels in layer 4, but not in layer 2, of schizophrenia subjects. These findings 
suggest that the dysregulated shift in ErbB4 splicing from major to minor variants occurs 
selectively in PV interneurons. Finally, the negative correlation between the JM-a/JM-b variants 
ratio and PV mRNA levels selectively in layer 4 of schizophrenia subjects supports the 
hypothesis that dysregulated splicing at the JM locus contributes to an activity-dependent down-
regulation of PV expression in schizophrenia. 
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In layer 2 we also detected non-significantly higher JM-a and lower JM-b levels in 
schizophrenia subjects, indicating a weak shift in splicing from JM-b to JM-a variants. 
Interestingly, ErbB4 is also present in most of the cholecystokinin-positive (CCK) interneurons 
as well as in ~ 10 to 30% of calbindin-positive interneurons, which together comprise ~18% of 
ErbB4-positive cells in the superficial layers (but only ~5 % in the middle layers) of primate 
DLPFC (Neddens et al., 2011). The majority of calbindin-positive cells also express somatostatin 
(SST) (Gonzalez-Albo et al., 2001). Therefore, although the majority of ErbB4 transcripts 
quantified in layer 2 are from CR interneurons, some proportion of these ErbB4 transcripts 
would likely be from CCK and SST interneurons. Interestingly, both CCK and SST mRNAs 
levels are lower in the DLPFC of schizophrenia subjects (Hashimoto et al., 2008b), suggesting 
that the modest shift in splicing at the JM locus in layer 2 of schizophrenia subjects may 
represent dysregulated ErbB4 splicing in these cell populations.  
The non-coding RNA MIAT was recently reported to regulate the alternative splicing of 
ErbB4 transcripts (Barry et al., 2014). In DLPFC total gray matter homogenates of our 62 subject 
pairs, MIAT levels were higher in schizophrenia subjects, positively correlated with the ratios of 
minor to major variants, and negatively correlated with PV mRNA levels across all subjects. 
These findings implicate higher MIAT levels as a possible mechanism responsible for the 
abnormal shifts in ErbB4 splicing in PV interneurons in schizophrenia. In support of this idea, 
MIAT levels were higher in VVA-positive PV interneurons but unaltered in total gray matter 
homogenates of schizophrenia subjects in the 14 subject pairs used for both the microarray and 
the qPCR analyses, demonstrating that MIAT levels are higher preferentially in PV interneurons 
in schizophrenia. 
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Converging evidence suggests that ErbB4 signaling positively regulates the activity of 
PV interneurons. ErbB4 signaling increases the formation of excitatory inputs onto PV 
interneurons by regulating the synaptic accumulation of PSD-95 (Ting et al., 2011; Del Pino et 
al., 2013) and the AMPA receptor subunit GluA1 (Abe et al., 2011). Moreover, ErbB4 activation 
inhibits the activity of Kv 1.1 channel in PV interneurons (Li et al., 2012) and decreases 
postsynaptic inhibitory currents by internalizing GABA(A) α1 receptors (Mitchell et al., 2013). 
Previous literature suggested that higher JM-a levels might lead to the loss of ErbB4 signaling, 
given the differential downstream consequences of the JM isoforms (Silberberg et al., 2006; Law 
et al., 2007; Joshi et al., 2014). Our data suggest that the PV-specific dysregulated splicing at the 
JM locus produces a gain of the JM-a isoform as well as a loss of the JM-b isoform in 
schizophrenia, which may additively contribute to impaired ErbB4 signaling in PV interneurons.  
Our study presents novel evidence for alterations in a molecular cascade that may 
contribute to PV interneuron dysfunction in schizophrenia. Specifically, higher MIAT levels in 
PV interneurons may lead to an abnormal shift in ErbB4 splicing from JM-b to JM-a variants, 
which would result in impaired ErbB4 signaling. Given the role of ErbB4 signaling in the 
formation of excitatory inputs, the resulting reduction in excitatory drive to PV neurons would 
lead to a corresponding activity-dependent down-regulation of PV expression in schizophrenia. 
Lower PV interneuron activity is associated with reduced cortical network activity at gamma-
band frequency (Sohal et al., 2009) which is required for normal cognitive functions, such as 
working memory (Fries, 2009). Indeed, patients with schizophrenia demonstrate lower gamma-
band power during working memory tasks (Cho et al., 2006). Thus, our findings suggest that 
dysregulated ErbB4 splicing may provide, at least in part, a molecular substrate for lower PV 
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interneuron activity that could contribute to impaired gamma oscillations and cognitive 
dysfunction in individuals with schizophrenia. 
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3.0  PATHOLOGICAL BASIS FOR DEFICIENT EXCITATORY DRIVE TO 
CORTICAL PARVALBUMIN INTERNEURONS IN SCHIZOPHRENIA 
Adapted from Chung DW, et al. (2016) Pathological basis for deficient excitatory drive to 
cortical parvalbumin interneurons in schizophrenia. Am J Psychiatry in press. 
3.1 INTRODUCTION 
Cognitive dysfunction is a core and clinically-critical feature of schizophrenia(Kahn and 
Keefe, 2013) but responds poorly to available medications(Keefe and Harvey, 2012). Therefore, 
identifying the neural substrate for these cognitive deficits is critical for the development of new 
therapeutic interventions. Certain cognitive deficits, such as impaired working memory, appear 
to emerge from altered gamma oscillations in the dorsolateral prefrontal cortex 
(DLPFC)(Uhlhaas and Singer, 2010). Because cortical gamma oscillations require the activity of 
parvalbumin-containing (PV) interneurons(Cardin et al., 2009; Sohal et al., 2009), deficient 
cortical PV interneuron activity could provide the neural substrate for altered prefrontal gamma 
oscillations and consequently impaired working memory in schizophrenia.  
Lower glutamatergic drive to PV interneurons has been hypothesized to be the cause of 
deficient PV interneuron activity in schizophrenia(Coyle et al., 2012; Gonzalez-Burgos and 
Lewis, 2012; Moghaddam and Krystal, 2012). This hypothesis is based on findings that 
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experimental manipulations in model systems which reduce glutamatergic drive to PV 
interneurons result in lower PV interneuron activity accompanied by lower expression of 
activity-dependent gene products (e.g., PV and the GABA-synthesizing enzyme glutamic acid 
decarboxylase 67, GAD67), abnormal gamma oscillations and working memory deficits(Behrens 
et al., 2007; Belforte et al., 2010; Del Pino et al., 2013; Pelkey et al., 2015). Consistent with this 
hypothesis, postmortem studies have repeatedly shown lower PV and GAD67 levels in the 
DLPFC of schizophrenia subjects(Akbarian et al., 1995; Volk et al., 2000; Hashimoto et al., 
2003; Fung et al., 2010; Curley et al., 2011), which are thought to reflect lower glutamatergic 
drive to a subset of PV neurons and not a loss of PV neurons in the illness(Akbarian et al., 1995; 
Woo et al., 1997; Hashimoto et al., 2003; Enwright et al., 2016). These deficits do not seem to be 
due to a global reduction in excitatory drive to all interneuron subtypes, as calretinin-containing 
(CR) interneurons, the most abundant interneuron subtype in the primate DLPFC(Conde et al., 
1994), appear to be relatively unaffected in schizophrenia(Hashimoto et al., 2003; Fung et al., 
2010; Chung et al., 2016b). However, the pathological basis for lower glutamatergic drive 
selectively onto PV interneurons, such as fewer excitatory synapses on these neurons, has not 
been identified in people with schizophrenia.  
Therefore, in this study, we used multi-labeling fluorescent immunohistochemistry, 
confocal imaging and a custom post-image processing method to directly assess excitatory 
synapses on parvalbumin-positive (PV+) neurons in the DLPFC from matched pairs of 
schizophrenia and unaffected comparison subjects. We tested the hypotheses that 1) lower PV 
levels in subjects with schizophrenia reflect altered PV expression per neuron and not a loss of 
PV+ neurons; 2) PV+, but not calretinin-positive (CR+), neurons receive fewer excitatory 
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synaptic inputs in subjects with schizophrenia; and 3) fewer excitatory synapses on PV+ neurons 
are associated with activity-dependent down-regulation of PV and GAD67 levels.  
3.2 MATERIALS AND METHODS 
3.2.1 Human subjects 
Brain specimens (N=40) were obtained during routine autopsies conducted at the 
Allegheny County Office of the Medical Examiner (Pittsburgh, PA) after consent was obtained 
from the next-of-kin. An independent team of clinicians made consensus DSM-IV diagnoses for 
each subject based on structured interviews with family members and review of medical records. 
The absence of a psychiatric diagnosis was confirmed in unaffected comparison subjects using 
the same approach. All procedures were approved by the University of Pittsburgh Committee for 
the Oversight of Research and Clinical Training Involving the Dead and the Institutional Review 
Board for Biomedical Research. The subjects were selected based on a postmortem interval 
(PMI) less than 24 hours in order to avoid the effect of PMI on protein immunoreactivity 
(Appendix C; Supplementary Methods). In addition, to control for the autofluorescence 
emitted by lipofuscin which accumulates with aging(Porta, 2002), all subjects were less than 62 
years of age. To control for experimental variance and to reduce biological variance, each subject 
with schizophrenia or schizoaffective disorder (N=20) was paired with one unaffected 
comparison subject for sex and as closely as possible for age (Appendix A; Table 3). The mean 
age, PMI and tissue storage time did not differ between subject groups (Table 2).  
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Table 2. Summary of demographic and postmortem characteristics of human subjects used in 
immunohistochemical assay. 
3.2.2 Fluorescent Immunohistochemistry 
Paraformaldehyde-fixed coronal tissue sections (40μm) containing DLPFC area 9 were 
processed for fluorescent immunohistochemistry as previously described(Glausier et al., 2014). 
Sections were pretreated for antigen retrieval (0.01M sodium citrate for 75 minutes at 80°C) and 
then incubated for 72 hours in the following primary antibodies:  PV (mouse, 1:1000, Swant, 
Bellinzona, Switzerland), CR (goat, 1:1000, Swant), post-synaptic density 95 (PSD95; rabbit, 
1:250, Cell Signaling, Danvers, MA) and vesicular glutamate transporter 1 (VGlut1; guinea pig, 
1:250, Millipore, Billerica, MA). Tissue sections were then incubated for 24 hours with 
secondary antibodies (donkey) conjugated to Alexa 488 (anti-mouse, 1:500), 568 (anti-rabbit, 
1:500), 647 (anti-guinea pig, 1:500, all from Invitrogen, Carlsbad, CA) or biotin (anti-goat, 
1:200, Fitzgerald, Acton, MA). Sections were then incubated with streptavidin 405 (1:200, 
invitrogen) for 24 hours. After washing, sections were mounted in the Prolong Gold Antifade 
reagent (Life technologies, Carlsbad, CA), coded to obscure diagnosis and subject number, and 
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stored at 4°C until imaging. All antibodies used in this study have been previously shown to 
specifically recognize the targeted protein (Appendix C; Supplementary Methods).  
3.2.3 Image Acquisition 
Images were acquired on an Olympus (Center Valley, PA, USA) IX81 inverted 
microscope equipped with an Olympus spinning disk confocal unit, a Hamamatsu EM-CCD 
digital camera (Bridgewater, NJ, USA), and a high-precision BioPrecision2 XYZ motorized 
stage with linear XYZ encoders (Ludl Electronic Products Ltd, Hawthorne, NJ, USA) using a 
60x 1.40 NA SC oil immersion objective. Ten image stacks (512×512 pixels; 0.25 µm z-step) in 
layer 2 or 4 from each section were selected using a previously published method for systematic 
random sampling(Sweet et al., 2009). Layer 2 or 4 was defined as 10-20% or 50-60% of the pia-
to-white matter distance, respectively(Pierri et al., 1999). We sampled these two layers as layer 4 
contains a high density of PV interneurons(Conde et al., 1994) and prominently lower PV 
mRNA levels in schizophrenia(Hashimoto et al., 2003; Chung et al., 2016b), whereas layer 2 
contains a high density of CR interneurons(Gabbott et al., 1997). The very low densities of PV 
interneurons in layer 2 and of CR interneurons in layer 4 precluded the sampling of these 
neurons. Lipofuscin for each stack was imaged using a custom fifth channel (excitation 
wavelength: 405nm; emission wavelength: 647nm) at a constant exposure time as previously 
described(Rocco et al., 2015). 
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3.2.4 Post-image Processing and Object Sampling 
Each fluorescent channel was deconvolved using the Autoquant's Blind Deconvolution 
algorithm to improve resolving power. VGlut1+ and PSD95+ puncta were used to identify the 
pre- and postsynaptic elements, respectively, as these molecular markers have been previously 
used to define excitatory synapses in PV interneurons(Chang et al., 2010; Del Pino et al., 2013; 
Donato et al., 2013). Masking of VGlut1+ and PSD95+ puncta was performed using the 
previously described method (Appendix C; Supplementary Methods and Figure 22). Edges of 
PV+ or CR+ cell bodies were segmented by the MATLAB edge function using the Canny edge 
detector operator(Canny, 1986). The edges of segmented objects were closed, filled and size-
gated (>80µm3) to limit the boundaries of PV+ or CR+ cell bodies. All PV+ and CR+ cell body 
masks were manually cleaned for final analyses (Appendix C; Figure 22). We sampled objects 
that localized within the middle 80% of z-planes (~32 μm), based on antibody penetration 
efficiency analyses to avoid edge effects (Appendix C; Supplementary Methods). The mean 
volume of tissue sampled did not differ between subject groups (layer 2: t19=0.3, p=0.776; layer 
4: t19=0.03, p=0.998). The mean numbers of VGlut1+ puncta and PSD95+ puncta sampled in 
layer 2 or layer 4 did not differ between subject groups (all t19<|1.6|, all p>0.12), indicating the 
absence of any group differences in cortical lamination. Numbers of VGlut1+/PSD95+ puncta 
per surface area of PV+ or CR+ cell bodies were calculated in order to determine the density of 
excitatory synapses on PV+ or CR+ neurons.  
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3.2.5 Antipsychotic-Exposed Monkeys 
Male monkeys (Macaca fasicularis) received oral doses of haloperidol (12–14 mg), 
olanzapine (5.5–6.6 mg) or placebo (N=6 per each group) twice daily for 17-27 months as 
previously described(Dorph-Petersen et al., 2005). Trough plasma levels for haloperidol and 
olanzapine were within the range associated with clinical efficacy in humans(Dorph-Petersen et 
al., 2005). Monkeys were euthanized in triads (one monkey from each of the three groups) on the 
same day. Coronal sections (40 μm) containing DLPFC area 9 from each monkey were 
processed for fluorescent immunohistochemistry as described above. 
3.2.6 Statistics 
Two analyses of covariance (ANCOVA) models were used to assess the main effect of 
diagnosis on the dependent measures. The paired ANCOVA model included subject pair as a 
blocking factor, and PMI and tissue storage time as covariates. This paired model accounts both 
for our attempts to balance diagnostic groups for sex and age and for the parallel tissue 
processing of both subjects in a pair, but is not a true statistical paired design.  Therefore, we also 
used an unpaired ANCOVA model that included sex, age, PMI and storage time as covariates. 
Most covariates were not significant and therefore were not included in the final analyses; 
exceptions included an effect of tissue storage time on the mean density of PSD95+ puncta on 
PV+ cell bodies (F1,35=5.5; p=0.025) by unpaired ANCOVA and an effect of storage time on the 
mean surface area of CR+ cell bodies (F1,18=6.5; p=0.021) and on the mean density of 
VGlut1+/PSD95+ puncta on CR+ cell bodies (F1,18=8.8; p=0.008) by paired ANCOVA. 
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The potential influence of co-morbid factors (e.g., diagnosis of schizoaffective disorder; 
history of substance dependence or abuse; nicotine use, antidepressant, or benzodiazepine and/or 
sodium valproate use at time of death; death by suicide) in the schizophrenia subjects was 
assessed by an ANCOVA model with each factor as the main effect and sex, age, PMI and 
storage time as covariates. Pearson’s correlation analysis was performed to assess the 
relationships between the density of VGlut1+/PSD95+ puncta on PV+ cell bodies and somal PV 
immunoreactivity levels or PV and GAD67 mRNA levels obtained from previously published 
studies(Kimoto et al., 2014; Volk et al., 2015). For the antipsychotic-exposed monkeys, an 
ANCOVA was used to assess the main effect of antipsychotic treatment on the dependent 
measures with triad as a blocking factor. 
3.3 RESULTS 
3.3.1 PV levels are lower in a subset of PV interneurons in schizophrenia 
We sampled PV+ neurons in DLPFC layer 4 (Figure 6A,B), as lower PV mRNA levels 
in schizophrenia are prominent in this layer(Hashimoto et al., 2003; Chung et al., 2016b). 
Consistent with those findings, mean PV protein levels in PV+ cell bodies were significantly 
34% lower in subjects with schizophrenia (Figure 6C). The mean numbers of PV+ neurons in 
identical volumes of sampled tissue did not differ between subject groups (Figure 6D). Finally, 
we observed a left shift in the frequency distribution of PV levels per PV+ cell body in 
schizophrenia subjects relative to comparison subjects (Figure 6E). Together, these findings 
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suggest that lower PV levels in schizophrenia reflect lower PV expression in a subset of PV 
neurons and not a deficit in PV neuron number. 
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Figure 6. Levels of PV immunoreactivity are significantly lower in PV interneurons in schizophrenia. 
(A, B) Representative sampling of PV+ neurons, illustrating the range of PV intensity levels, from one subject pair used in this study (healthy comparison 
subject: Hu1543, 19 cells collected; schizophrenia subject: Hu10026, 18 cells collected). * denotes PV+ neurons shown in Figure 1. Scale bars = 10 μm. (C-F) 
Scatter plots show the levels of dependent measures (indicated in the heading of each graph) for each healthy comparison and schizophrenia subject in a pair 
(open circles). Data points below the diagonal unity line indicate a lower level in the schizophrenia subject relative to the matched healthy comparison subject. 
Statistics from both paired and unpaired ANCOVA analyses are shown for each dependent measure. (C) Mean (±SD) somal PV immunoreactivity levels in PV+ 
cell bodies were significantly lower in schizophrenia subjects relative to comparison subjects (schizophrenia: 3.8X108±2.0X108, comparison: 5.7X108±1.5X108), 
(D) whereas the mean numbers of PV+ neurons sampled did not differ between subject groups (schizophrenia: 17.7±6.0, comparison: 18.5±4.6). (E) The 
frequency distributions of somal PV intensity values of PV+ neurons sampled from schizophrenia subjects (light gray) and healthy comparison subjects (dark 
gray). Each bin represents 1x108 a.u. 
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3.3.2 PV interneurons receive fewer excitatory synaptic inputs in schizophrenia 
The pre- and postsynaptic elements of excitatory synapses on PV+ neurons were 
identified by VGlut1+ puncta and PSD95+ puncta, respectively (Figure 7A, B). Excitatory 
synapses were defined by the overlap of VGlut1+ and PSD95+ (VGlut1+/PSD95+) puncta. The 
mean density of VGlut1+/PSD95+ puncta on PV+ cell bodies was significantly 18% lower in 
schizophrenia subjects (Figure 7C). The mean densities of VGlut1+ or PSD95+ puncta on PV+ 
cell bodies were also significantly 12% or 19% lower, respectively, in schizophrenia subjects 
(Figure 7D, E), reflecting fewer pre- and postsynaptic glutamatergic structures on PV+ neurons.  
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Figure 7. Density of excitatory synaptic inputs to PV interneurons is significantly lower in schizophrenia 
(A, B) Representative masked images of VGlut1+ puncta (green), PSD95+ puncta (red) and PV+ cell bodies (gray) from the subject pair shown in Figure 6. 
Excitatory synaptic inputs to PV+ neurons were identified by the overlap of VGlut1+/PSD95+ puncta (yellow) within a PV+ cell body (black arrows, inset image 
#1). Overlapping VGlut1+/PSD95+ where only the PSD95+ puncta (white arrowheads, inset image #2) or VGlut1+ puncta (black arrowheads, inset image #3) 
were located within a PV cell body were not included as excitatory inputs. Scale bars = 10 μm. (C) Mean (±SD) density of VGlut1+/PSD95+ puncta 
(schizophrenia: 0.0335±0.008, comparison: 0.0409±0.008), (D) VGlut1+ puncta (schizophrenia: 0.0492±0.007, comparison: 0.0558±0.007) and (E) PSD95+ 
puncta (schizophrenia: 0.0857±0.016, comparison: 0.106±0.010) overlapping with PV+ cell bodies were all significantly lower in schizophrenia subjects relative 
to comparison subjects. (F) Mean surface area of PV+ cell bodies did not differ between subject groups (schizophrenia: 684±111, comparison: 745±96). 
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3.3.3 Fewer excitatory synapses on PV interneurons are not affected by methodological 
confounds or disease-associated co-morbid factors 
The mean surface area of PV+ cell bodies did not differ between subject groups (Figure 
7F), indicating that the lower density of excitatory synapses on PV+ neurons in schizophrenia is 
not due to a larger surface area of PV+ cell bodies. The mean VGlut1 or PSD95 protein levels in 
labeled puncta on PV+ cell bodies did not differ between subject groups (Appendix C; Figure 
23), suggesting that our findings of fewer synaptic structures in schizophrenia were not biased by 
lower levels of synaptic markers. Finally, the mean density of VGlut1+/PSD95+ puncta on PV+ 
cell bodies did not differ among schizophrenia subjects as a function of assessed co-morbid 
factors (Appendix C; Figure 24) and was not altered in monkeys chronically exposed to 
psychotropic medications (Appendix C; Figure 25). Together, these findings suggest that fewer 
excitatory synapses on PV+ neurons reflect the disease process of schizophrenia, and are not due 
to methodological confounds or other factors commonly associated with the illness. 
3.3.4 CR interneurons do not receive fewer excitatory synaptic inputs in schizophrenia 
In order to determine the cell type-specificity of fewer excitatory synapses on PV+ 
neurons, we measured the density of excitatory synapses on CR+ neurons. The mean numbers of 
sampled CR+ neurons, mean somal CR protein levels and mean surface area of CR+ cell bodies 
did not differ between subject groups (Figure 8A-C). The mean density of VGlut1+/PSD95+ 
puncta on CR+ cell bodies was non-significantly 9% higher in schizophrenia subjects (Figure 
8D), demonstrating that the number of excitatory synapses on CR+ neurons is not lower in the 
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illness.
 
Figure 8. Density of excitatory synaptic inputs to CR interneurons is modestly higher in schizophrenia 
(A-C) Mean numbers of sampled CR+ neurons (schizophrenia: 24.3±6.7, comparison: 24.5±5.9), mean CR 
immunoreactivity levels in CR+ cell bodies (schizophrenia: 6.8X107±2.0X107, comparison: 7.5X107±1.5X107) or 
mean surface area of CR+ cell bodies schizophrenia: 336±28, comparison: 347±34) did not differ between subject 
groups. (D) Mean density of VGlut1+/PSD95+ puncta onto CR+ cell bodies was non-significantly higher in 
schizophrenia subjects (schizophrenia: 0.0257±0.005, comparison: 0.0236±0.005). 
3.3.5 Validation of methods for quantifying excitatory synaptic inputs 
We have previously shown by duel-labeling electron microscopy that the density of 
excitatory synapses is significantly 1.90 fold higher on PV+ than CR+ neurons in the primate 
DLPFC(Melchitzky and Lewis, 2003). Consistent with these findings, the mean density of 
VGlut1+/PSD95+ puncta on PV+ cell bodies was significantly (t19=8.5, p<0.001) 1.73 fold 
higher than on CR+ cell bodies in the comparison subjects in the present study. This finding 
indicates that the light microscopic methods used here provide a robust means for sampling 
excitatory synaptic inputs specific to PV+ or CR+ neurons. 
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3.3.6 Excitatory synapses on PV interneurons predict PV and GAD67 expression levels in 
human DLPFC 
Finally, we assessed whether the density of excitatory synapses on PV+ neurons 
predicted levels of PV and GAD67, molecular markers of PV interneuron activity. Mean density 
of VGlut1+/PSD95+ puncta on PV+ cell bodies was positively correlated with PV and GAD67 
mRNA levels in schizophrenia subjects but not in comparison subjects (Figure 9A, B). In 
addition, the mean density of VGlut1+/PSD95+ puncta on PV+ cell bodies positively predicted 
the mean somal PV immunoreactivity levels in schizophrenia subjects but not in comparison 
subjects (Figure 9C). Moreover, this positive correlation was evident across all sampled PV+ 
neurons in both subject groups (Figure 9D). Among these neurons, the PV+ neurons with the 
lowest PV levels (more than one standard deviation below the mean) had a density of 
VGlut1+/PSD95+ puncta significantly (t112=-5.4; p<0.001) 42% lower than the PV+ neurons 
with the highest PV levels (more than one standard deviation above the mean). 
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Figure 9. Lower density of excitatory synaptic inputs to PV interneurons is associated with lower PV and 
GAD67 expression in human DLPFC 
(A, B) Across all subjects, the mean density of VGlut1+/PSD95+ puncta onto PV+ cell bodies positively 
predicted the relative levels of PV and GAD67 mRNAs. (C) Across all subjects and (D) across all sampled 
PV+ neurons (N=725), the density of VGlut1+/PSD95+ puncta onto PV+ cell bodies positively predicted 
somal PV immunoreactivity levels.  
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3.4 DISCUSSION 
A pathological substrate for reduced glutamatergic drive onto PV interneurons in 
schizophrenia has not been previously identified due to the technical challenges of resolving 
synaptic abnormalities in a cell type-specific manner in postmortem human brain. Here, we 
report for the first time that the neuropathology of schizophrenia includes a lower number of 
excitatory synapses on PV interneurons. This deficit appears to reflect the disease process of 
schizophrenia and is not due to methodological confounds or other factors commonly associated 
with the illness. First, fewer excitatory synapses on PV+ neurons were evident from lower 
numbers of both pre- and postsynaptic markers, validating deficits in the synaptic structures. 
Second, these deficits were not confounded by either a larger surface area of PV+ cell bodies or 
undetectable levels of protein markers within existing synaptic structures in schizophrenia 
subjects. Third, none of the assessed schizophrenia-associated co-morbid factors accounted for 
these deficits. Fourth, long-term exposure to psychotropic medications did not alter the density 
of excitatory synapses on PV+ neurons in the DLPFC of non-human primates; the effect of 
antipsychotics could not be assessed in humans as only one schizophrenia subject had not been 
exposed to these medications. Fifth, the density of excitatory synapses on CR+ neurons was not 
lower in the illness, consistent with a prominent pathology of PV interneurons in schizophrenia. 
Finally, the density of excitatory synapses on PV+ neurons predicted levels of the activity-
dependent gene products PV and GAD67 selectively in the schizophrenia subjects. Together, 
these findings support the hypothesis that fewer excitatory synapses selectively on cortical PV 
interneurons provide a pathological substrate for deficient excitatory drive to these interneurons 
in schizophrenia. 
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PV interneurons comprise two main subtypes: PV basket neurons target the proximal 
dendrites and cell bodies of pyramidal neurons and PV chandelier neurons synapse onto the axon 
initial segment of pyramidal neurons(Williams et al., 1992). Although both populations of PV 
interneuron subtypes are active during gamma oscillations, gamma rhythms are more strongly 
coupled to the activity of PV basket neurons(Dugladze et al., 2012; Massi et al., 2012). Given the 
much greater prevalence of PV basket neurons in the middle layers of the primate 
DLPFC(Krimer et al., 2005; Zaitsev et al., 2005), most of the PV+ neurons sampled in our study 
are likely to be PV basket neurons.  
Our sampling of excitatory synapses on PV+ neurons is limited in two respects. First, we 
did not sample vesicular glutamate transporter 2-containing excitatory inputs that represent 
projections from the thalamus(Fremeau et al., 2001). However, thalamic axons represent a small 
minority (<10%) of excitatory terminals in the cortex(Latawiec et al., 2000) and only a small 
percentage of thalamic inputs target PV interneurons(Rotaru et al., 2005), suggesting that the 
excitation of PV interneurons is mostly driven by cortical excitatory inputs. Second, we did not 
sample synaptic inputs to dendrites of PV interneurons due to the few dendrites originating from 
PV+ cell bodies, with detectable PV immunoreactivity. Although the density of excitatory 
synapses is higher onto dendrites than cell bodies of PV interneurons (30), depolarization of the 
cell body of PV interneurons is much stronger for somal than dendritic excitatory inputs (31,32). 
However, despite these limitations, the density of excitatory cortical synapses on PV+ cell bodies 
in the present study predicted activity-dependent PV expression across all PV+ neurons. 
Therefore, our approach was sufficiently sensitive to detect an apparently functionally 
meaningful deficit in excitatory synaptic inputs to PV+ neurons in schizophrenia subjects. 
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Multiple signaling pathways regulate the formation of excitatory synapses on PV 
interneurons. For example, the ErbB4 signaling pathway induces the formation of excitatory 
synapses on PV interneurons(Ting et al., 2011; Del Pino et al., 2013; Mei and Nave, 2014) and 
the release of neuronal pentraxin 2 (Narp) from pyramidal cells recruits excitatory synapses 
selectively on PV interneurons in an activity-dependent manner(Chang et al., 2010). Both an 
abnormal shift in ErbB4 splicing at the JM locus(Law et al., 2007; Joshi et al., 2014) and lower 
Narp transcript levels have been shown in the DLPFC of subjects with schizophrenia, including 
those included in the present study(Kimoto et al., 2015; Chung et al., 2016b). Across these 
subjects, the density of VGlut1+/PSD95+ puncta on PV+ cell bodies was significantly correlated 
with the ratio of ErbB4 JM-a to JM-b splice variants in cortical layer 4 (R=-0.436, p=0.005) and 
with Narp mRNA levels in total gray matter (R=0.351, p=0.026). These findings suggest that 
alterations in the ErbB4 and/or Narp signaling pathways could be upstream of the deficit in 
excitatory synaptic inputs to, and consequently the lower activity of, PV interneurons in 
schizophrenia.  
Consistent with the idea that PV interneuron activity is reduced in the illness, activity-
dependent expression levels of GAD67 are lower in the DLPFC of subjects with schizophrenia, 
and specifically in PV interneurons(Volk et al., 2000; Curley et al., 2011). Experimental 
reductions of GAD67 in PV interneurons decrease inhibitory synaptic transmission in pyramidal 
cells and alter cortical network activity(Brown et al., 2015; Lazarus et al., 2015; Georgiev et al., 
2016). Strong inhibition of pyramidal cells by PV interneurons is required for the generation of 
gamma oscillations in the DLPFC associated with working memory. Thus, the lower density of 
excitatory synapses on PV+ neurons and the corresponding deficit in GAD67 expression found 
in the present study could provide a pathological substrate for deficient inhibition of pyramidal 
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cells by PV interneurons, which in turn would result in impaired gamma oscillations and 
working memory deficits in people with schizophrenia. 
Discovering pathological entities that bridge etiopathogenic pathways to the core features 
of the illness is essential for understanding the disease process of schizophrenia. For example, 
disruptions in the ErbB4 or Narp signaling pathways in the DLFPC could be upstream of the 
deficits in excitatory synaptic inputs to PV interneurons in schizophrenia. Given that PV 
interneuron activity is essential for gamma oscillations, these deficits could underlie the 
downstream pathophysiology of impaired gamma oscillations and consequently working 
memory dysfunction in schizophrenia. Therefore, fewer excitatory synapses on PV interneurons 
might serve as a common pathological locus upon which diverse streams of etiopathogenic 
pathways converge in order to produce a core pathophysiological feature of schizophrenia from 
which cognitive dysfunction emerges. 
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4.0  DEVELOPMENTAL PRUNING OF EXCITATORY INPUTS TO 
PARVALBUMIN INTERNEURONS IN MONKEY PREFRONTAL CORTEX: 
CONTRIBUTION OF ERBB4 SPLICING 
4.1 INTRODUCTION 
In primates, certain complex cognitive processes, such as working memory, depend in 
part on the proper activation of specific neural circuits in the dorsolateral prefrontal cortex 
(DLPFC) (Goldman-Rakic, 1995). In both monkeys and humans, recruitment of DLPFC activity 
and performance during working memory tasks continue to improve through adolescence 
(Alexander, 1982; Goldman-Rakic, 1987; Luna et al., 2010). During this period, excitatory 
synapses and their principal targets, pyramidal neuron dendritic spines, massively decline in 
number in the primate DLPFC (Huttenlocher, 1979; Bourgeois et al., 1994; Anderson et al., 
1995; Petanjek et al., 2011). Synaptic pruning is thought to eliminate unwanted or imprecise 
connections and to strengthen the remaining connections (Lichtman and Colman, 2000; Holtmaat 
and Svoboda, 2009), suggesting that this process could contribute to the maturation of working 
memory function during adolescence. 
Working memory is thought to emerge from oscillatory activity of DLPFC neurons at 
gamma frequency (30-80 Hz) (Fries, 2009), which requires the activity of local GABAergic 
interneurons that express the calcium binding protein parvalbumin (PV) (Cardin et al., 2009; 
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Sohal et al., 2009). During working memory tasks, excitation from pyramidal neurons recruits 
PV interneurons, which in turn provide phasic inhibition that synchronizes the firing of 
pyramidal neurons at gamma frequency (Gonzalez-Burgos et al., 2015a). Due to the narrow time 
window of PV interneuron recruitment during gamma oscillations, PV interneurons require 
efficient detection of glutamatergic inputs with high precision (Jonas et al., 2004; Hu et al., 
2014). Therefore, pruning of unnecessary synaptic connections and strengthening of the 
remaining excitatory inputs to PV interneurons during development could play a crucial role in 
improving PV interneuron recruitment during gamma oscillations and consequently in the 
maturation of working memory function. However, evidence for pruning of excitatory synapses 
on PV interneurons in the DLPFC, and the molecular mechanisms that could regulate cell type-
specific pruning, have not been reported. 
Excitatory synapses on PV interneurons are modulated in part by receptor tyrosine kinase 
ErbB4 (Rico and Marin, 2011; Mei and Nave, 2014). Activation of ErbB4 increases the number 
of excitatory synapses (Ting et al., 2011) and the loss of ErbB4 results in fewer excitatory 
synapses on PV interneurons (Del Pino et al., 2013). Moreover, ErbB4 transcripts are 
alternatively spliced at two loci, generating four different splice variants with distinct 
downstream signaling pathways (Veikkolainen et al., 2011). Although their functional 
consequences are not known in PV interneurons, major and minor ErbB4 variants exert opposing 
physiological effects in non-neuronal cells (Muraoka-Cook et al., 2009; Sundvall et al., 2010). 
Thus, shifts in the expression level and/or splicing of ErbB4 in PV interneurons during 
adolescence might function as a developmental switch regulating the pruning of excitatory 
synapses on these neurons. 
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In this study, we tested the hypotheses that 1) excitatory synapses on PV interneurons are 
pruned during postnatal development in monkey DLPFC and 2) this pruning process is 
attributable to shifts in the expression levels and/or splicing of ErbB4 transcripts. We found that 
excitatory synapses on PV interneurons undergo pruning during adolescence in monkey DLPFC. 
Moreover, total ErbB4 expression did not change but the alternative splicing of ErbB4 transcripts 
shifted from the major to minor variants with age. Overexpression of ErbB4 major variant 
increased the number of excitatory synapses on PV neurons, whereas the minor variant had no 
effect. Finally, the ratio of minor to major splice variants predicted the pruning of excitatory 
synapses on PV interneurons across all monkeys. Thus, our findings indicate that shifts in ErbB4 
splicing in PV interneurons modulate the pruning of excitatory synapses on these neurons during 
postnatal development. 
4.2 MATERIALS AND METHODS 
4.2.1 Animals and tissue preparation 
We studied 13 female rhesus monkeys (Macacca mulatta) of two age groups: postnatal 3 
to 9 months (Pre-pubertal group; n=7) and 42 to 46 months (Post-pubertal group; n=6); these age 
groups capture the plateau phase and the declining phase, respectively, of excitatory synapse 
density in the primate DLPFC (Bourgeois et al., 1994). Housing and experimental procedures 
were conducted in accordance with guidelines set by the United States Department of 
Agriculture and the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals and with the approval of the University of Pittsburgh's Institutional Animal Care and 
 55 
Use Committee. Animals were perfused transcardially with ice-cold artificial cerebrospinal fluid 
following ketamine and pentobarbital-induced anesthesia. The brain was removed and the right 
hemisphere was blocked coronally, frozen in isopentane on dry ice and stored at -80ºC. The left 
hemisphere was blocked coronally, immersed in phosphate-buffered 4% paraformaldehyde at 
4ºC for 48 hours, washed in sucrose solutions at 4ºC and stored at -30ºC in a cryoprotectant 
solution containing glycerin and ethylene glycol (Gonzalez-Burgos et al., 2015b). 
4.2.2 Layer-specific RNA Extraction and qPCR 
Cryostat sections (12 µm) containing right DLPFC area 46 were mounted on glass 
polyethylene naphthalate membrane slides (Leica Microsystems, Bannockburn, IL), fixed in 
ethanol/sodium acetate, stained in 0.5% thionin and dehydrated with ethanol. The boundaries of 
layer 4 were determined on the basis of the size and packing density of stained neurons (Chung 
et al., 2016b). A Leica microdissection system (LMD 6500, Leica Microsystems, Wetzlar, 
Germany) was used to collect ~3x106 µm2 of tissue from layer 4 of each monkey. The collected 
tissue samples were lysed by vortexing for 30 seconds in 200 μl of RLTplus buffer (Qiagen, 
Valencia, CA). RNA was extracted using the RNeasy Plus Micro Kit (Qiagen, Germantown, 
MD), and complementary DNA was synthesized using the qScript cDNA SuperMix (Quanta 
Bioscience, Gaithersburg, MD). The qPCR reactions were performed in quadruplicate using an 
ABI StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA) with 
previously described primer sets for PV, four ErbB4 splicing variants (JM-a, JM-b, CYT-1, 
CYT-2), and pan-ErbB4 (Chung et al., 2016b). Beta-actin and cyclophilin A were used as 
reference genes to normalize the expression levels of transcripts, as these house-keeping genes 
have stable levels of expression across postnatal development in monkey DLPFC (Volk et al., 
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2012a). The delta cycle thresholds (dCTs) were calculated for each sample by using the 
geometric mean of the two endogenous reference genes as the normalizing factor. Then the 
expression level for each transcript was calculated as the expression ratio value (expression 
ratio=2–dCTs). 
4.2.3 Fluorescent Immunohistochemistry 
Cryostat sections (40 µm) containing left DLPFC area 46 were pretreated for antigen 
retrieval (0.01M sodium citrate for 75 minutes at 80°C) and then incubated for 72 hours at 4ºC in 
the following primary antibodies: PV (mouse, 1:1000, Swant, Bellinzona, Switzerland), 
postsynaptic density 95 (PSD95; rabbit, 1:250, Cell Signaling, Danvers, MA) and vesicular 
glutamate transporter 1 (VGlut1; guinea pig, 1:250, Millipore, Billerica, MA). Tissue sections 
were washed three times in phosphate-buffered saline (PBS) and then incubated for 24 hours at 
4ºC with secondary antibodies (donkey) conjugated to Alexa 488 (anti-mouse, 1:500, Invitrogen, 
Carlsbad, CA), 568 (anti-rabbit, 1:500, Invitrogen) or 647 (anti-guinea pig, 1:500, Millipore). 
After washing three times in PBS, sections were mounted in the Prolong Gold Antifade reagent 
(Life Technologies, Carlsbad, CA) and stored at 4°C until imaging. The specificity of these 
antibodies has been described previously (Chung et al., 2016a). 
4.2.4 ErbB4 Plasmid Cloning 
Full length cDNAs encoding ErbB4 JM-a/CYT-1 variant (Huang et al., 2000) (a gift from 
Dr. Lin Mei) or JM-b/CYT-1 variant (Sardi et al., 2006) (a gift from Dr. Gabriel Corfas) were 
amplified using a primer pair ErbB4_Exon1_Bgl II_F (ACGTAGATCTATGAAGCCGGCGAC 
 57 
AGGACTTTGG) and ErbB4_Exon28_Sal I_R (ACGTGTCGACTTACACCACAGTATTCCG 
GTGTCTG). The amplified products were digested with Bgl II and Sal I and ligated with T4 
ligase (Invitrogen) into Pires2-DsRed-Express2 vector (Clontech, Mountain View, CA). Pires2 
vector contains an internal ribosome entry site (IRES) between cloning sites and fluorescent 
protein coding region, which allows both the gene of interest and the fluorescent protein to be 
translated from a single mRNA in mammalian cells (Chung et al., 2011). In order to generate 
cDNA encoding the JM-b/CYT-2 variant, the DNA sequence corresponding to exon 26 of JM-
b/CYT-1 was deleted using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent 
Technologies, Santa Clara, CA) with a primer pair Del172-219_F (ATCTCGGTATACAAACT 
GGTTCCTATTCGAGTCAATTCTTGC) and Del172-219_R (GCAAGAATTGACTCGAATA 
GGAACCAGTTTGTATACCGAGAT). The DNA sequence of all constructs was verified by 
sequencing. 
4.2.5 Dissociated Neuronal Culture and Immunocytochemistry 
Dissociated rat cortical neurons were prepared from postnatal day 1 Long-Evans rats 
(Charles River Laboratories, Inc., Wilmington, MA). In 24-well plates, cortical neurons were 
placed at 1x105 cells per well on acid-washed coverslips coated with poly-D-lysine (20 µg/mL) 
and laminin (3.4 µg/mL). Cortical neurons were maintained in Neurobasal Medium 
supplemented with B27 (all from Invitrogen), penicillin/streptomycin (100 U/mL and 100 
mg/mL, respectively), and 2mM glutamine. One half of the media in each well was replaced 
every 4 days. At 7 days in vitro (DIV) cortical neurons were transfected with 1 µg of DNA 
plasmid per well using the Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
instructions. Neurons at 21 DIV were fixed for 8 minutes at room temperature with 4% 
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paraformaldehyde/4% sucrose in PBS. Fixed neurons were washed with PBS and then incubated 
for 24 hours at 4ºC in 1X GDB (15 mM phosphate buffer [pH 7.4] containing 0.1% gelatin, 0.3% 
Triton X-100, and 0.25M NaCl) (Wills et al., 2012) with the following primary antibodies: PV 
(goat, 1:500, Swant), DsRed (rabbit, 1:500, Abcam, Cambridge, MA), PSD95 (mouse, 1:250, 
Synaptic Systems, Gottingen, Germany) and VGlut1 (guinea pig, 1:2000, Synaptic Systems). 
Neurons were washed three times in PBS and then incubated for 2 hours with secondary 
antibodies (donkey) conjugated to Alexa 405 (anti-goat, 1:500, Abcam), 488 (anti-mouse, 1:500, 
Invitrogen), 568 (anti-rabbit, 1:500, Invitrogen) and 647 (anti-guinea pig, 1:500, Millipore). 
Coverslips were mounted using the Fluoromount-G (Southern Biotech, Birmingham, AL). All 
antibodies have been shown to specifically recognize the targeted protein as reported by the 
manufacturer. 
4.2.6 Image Acquisition 
Images containing monkey sections were acquired on an Olympus (Center Valley, PA) 
IX81 microscope with a spinning disk confocal unit and a Hamamatsu EM-CCD digital camera 
(Bridgewater, NJ) at 60x magnification. Ten image stacks (512×512 pixel; 0.25 µm z-step) in 
layer 4, defined as 50-60% of the pia-to-white matter distance, per each section were selected 
using a previously published method for systematic random sampling (Sweet et al., 2009). The 
mean numbers of PV-immunoreactive neurons sampled in the same volume of tissue did not 
differ between age groups (t11=0.06, p=0.952). Images containing primary neurons were acquired 
on a Nikon (Melville, NY) A1R laser scanning confocal microscope at 60x magnification. In 
each experiment, all image stacks (1024x1024 pixels; 0.5 µm z-step) were acquired with 
identical settings for laser power, detector gain and amplifier offset, with pinhole diameters set 
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for 1.2 airy unit. Images were rendered using a maximal intensity projection algorithm. Each 
experimental condition comprised 10 to 12 DsRed+/PV+ neurons and the final data sets 
comprised 3 independent experiments.  
4.2.7 Post-image Processing 
For images containing monkey sections, each fluorescent channel was deconvolved using 
the Autoquant's Blind Deconvolution algorithm to improve image contrast by reducing out-of-
focus fluorescence. Pre- and postsynaptic elements of excitatory synapses were defined as 
VGlut1+ and PSD95+ puncta, respectively. Masking of VGlut1+ and PSD95+ puncta and PV 
cell body was performed using the previously described method (See Appendix D; 
Supplementary Methods) (Chung et al., 2016a). Excitatory synapses on PV interneurons were 
defined by the overlap of VGlut1+ and PSD95+ (VGlut1+/PSD95+) puncta within PV cell 
bodies (Fig. 10). The validity of this approach was confirmed by a prior comparison of the data 
from the same approach (Chung et al., 2016a) and the results from a previous electron 
microscopy (EM) study (Melchitzky and Lewis, 2003). For images containing primary neurons, 
the VGlut1+ and PSD95+ puncta were masked using the binary threshold function in NIS-
Elements AR software (Nikon). The proximal dendrites were defined as neurites containing 
PSD95+ puncta within 30µm from the PV+/DsRed+ cell body as previously characterized (Ting 
et al., 2011). The cell body and one randomly selected proximal dendrite from each sampled 
PV+/DsRed+ neuron were manually masked. 
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Figure 10. Sampling of excitatory synapses on PV interneurons in monkey DLPFC layer 4 
(A) Representative deconvolved image of monkey DLPFC layer 4 labeled with antibodies against PV (gray), VGlut1 (green) and PSD95 (red). Scale bar = 10 
μm. (B) Single (white) and combined (color) mask images of PV cell body, VGlut1+ puncta and PSD95+ puncta from the boxed area in (A). Combined mask 
image displays only overlapping VGlut1+ and PSD95+ puncta (yellow). Excitatory synapses on PV cell bodies were defined by the VGlut1+/PSD95+ puncta 
within a PV cell body, as indicated by yellow arrowheads. Overlapping VGlut1+/PSD95+, where only the PSD95+ puncta or the VGlut1+ puncta were located 
within a PV cell body, were not counted as excitatory synapses. Scale bar = 5 μm. 
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4.2.8 Statistics 
Student’s t-tests were performed to compare the dependent measures between age groups. 
Pearson’s correlation analyses were performed to assess the association between the ErbB4 
splice variant ratios and the density of VGlut1+, PSD95+ or VGlut1+/PSD95+ puncta on PV cell 
bodies across all animals. One-way analysis of variance (ANOVA) was used to assess the main 
effect of Pires2 constructs on the dependent measures in primary neuronal culture. 
4.3 RESULTS 
4.3.1 Developmental pruning of excitatory synapses on PV interneurons in layer 4 of 
monkey DLPFC 
PV neurons were sampled in DLPFC layer 4 as this cortical layer has been shown to 
contain the highest density of PV neurons in monkey DLPFC (Conde et al., 1994). The mean 
(±SD) density of VGlut1+/PSD95+ puncta on PV cell bodies was significantly (t11=2.4, p=0.034) 
26% lower in the post-pubertal (0.026±0.005 per µm2) relative to the pre-pubertal group 
(0.035±0.007 per µm2; Fig. 11A), indicating that excitatory synapses on PV interneurons are 
pruned during adolescence. Consistent with the mean group difference, the frequency 
distribution of VGlut1+/PSD95+ puncta density on individual PV cell bodies was shifted to the 
left in post-pubertal relative to pre-pubertal animals (Fig. 11B). The mean surface area of PV cell 
bodies did not differ between age groups (Pre-pubertal: 674±64 µm2, Post-pubertal: 662±73 µm2; 
 62 
t11=0.3, p=0.770; Fig. 11C), demonstrating that the lower density of excitatory synapses on PV 
neurons in the post-pubertal animals is not due to a larger surface area of PV cell bodies. 
Moreover, the density of total VGlut1+/PSD95+ puncta in DLPFC layer 4 did not differ between 
age groups (Pre-pubertal: 0.061±0.011 per µm3, Post-pubertal: 0.056±0.008 per µm3; t11=0.9, 
p=0.368; Fig. 11D), suggesting that the pruning of excitatory synapses during adolescence is 
more pronounced on PV interneurons than on other neural elements in DLPFC layer 4. Finally, 
the mean synaptic levels (i.e., relative fluorescence intensities within VGlut1+/PSD95+ puncta 
on PV cell bodies) of VGlut1 (Pre-pubertal: 6.0x105±1.3x105 a.u., Post-pubertal: 
7.9x105±2.1x105 a.u.; t11=-2.0, p=0.069; Fig. 11E) and PSD95 (Pre-pubertal: 2.7x105±0.7x105 
a.u., Post-pubertal: 3.9x105±0.7x105 a.u.; t11=-3.1, p=0.010; Fig. 11F) proteins were 32% and 
43% higher, respectively, in the post-pubertal group. These findings suggest that the maturation 
of excitatory synaptic inputs to cortical PV interneurons during adolescence involves the pruning 
of a subset of synapses and higher levels of VGlut1 and PSD95 proteins in the remaining 
synapses. 
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Figure 11. Developmental pruning of excitatory synapses on PV interneurons through adolescence in layer 4 
of monkey DLPFC 
(A, C-F) Group mean (bar) and individual monkey (open circles) levels of dependent measures, as indicated by the 
y-axis labels, in DLPFC layer 4 of monkeys in pre-pubertal group (blue) or post-pubertal group (red). Statistics from 
student’s t-test for each dependent measures are shown above the corresponding graph. (A) Mean density of 
VGlut1+/PSD95+ puncta on PV cell bodies was significantly lower in the post-pubertal group. (B) The frequency 
distributions of VGlut1+/PSD95+ puncta density on PV cell bodies sampled from pre-pubertal monkeys (blue) and 
post-pubertal monkeys (red). Each bin represents 0.05 puncta per µm2. (C-D) The mean surface area of PV cell 
bodies (C) and the density of total VGlut1+/PSD95+ puncta in DLPFC layer 4 (D) did not differ between age 
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groups. (E-F) Mean VGlut1 (E) and PSD95 (F) levels within VGlut1+/PSD95+ puncta on PV cell bodies were 
higher in the post-pubertal group.  
 
4.3.2 Association between maturation of excitatory synapses on PV interneurons and PV 
levels 
As PV expression depends on neuronal activity (Behrens et al., 2007; Belforte et al., 
2010; Del Pino et al., 2013), we next assessed changes in PV immunoreactivity between age 
groups. Mean PV protein levels per neuron were significantly (t11=-3.5, p=0.005) 73% higher in 
the post-pubertal (4.2x108±0.7x108 a.u.) relative to the pre-pubertal group (2.4x108±1.0x108 a.u.; 
Fig. 12A). Moreover, mean PV protein levels per neuron were negatively correlated with the 
mean density of VGlut1+/PSD95+ puncta on PV cell bodies (R=-0.620, p=0.024; Fig. 12B) and 
positively correlated with the mean synaptic VGlut1 (R=0.603, p=0.029; Fig. 12C) and PSD95 
levels (R=0.720, p=0.006; Fig. 12D) across all animals. These data suggest that although a 
subset of excitatory synaptic inputs to PV interneurons is pruned during adolescence, the 
increase in VGlut1 and PSD95 levels in the remaining excitatory synapses contribute to the 
developmental up-regulation of activity-dependent PV expression.  
 
 
 
 
 65 
 
Figure 12. Lower density of excitatory synapses on PV interneurons and higher synaptic levels of VGlut1 and PSD95 proteins predict higher PV levels 
across all animals 
(A) Group mean (bar) and individual monkey (open circles) levels of PV immunoreactivity in PV cell bodies for each age group. Mean PV 
immunoreactivity levels in PV cell bodies were significantly higher in post-pubertal group relative to pre-pubertal group. Statistic from student’s t-test is 
shown above the graph. (B-D), Correlation graphs plotting the mean PV intensity in PV cell bodies on the y-axis and the mean density of 
VGlut1+/PSD95+ puncta on PV cell bodies (B), mean synaptic VGlut1 intensity (C), or mean synaptic PSD95 intensity (D) on the x-axis. Trendlines 
represent significant regression line across all animals (n=13). 
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4.3.3 Developmental shifts in alternative splicing of ErbB4 transcripts in layer 4 of 
monkey DLPFC 
Next, we assessed differences in the expression level and alternative splicing of ErbB4 
transcripts in PV interneurons between age groups. In the primate DLPFC, most ErbB4-positive 
neurons contain either PV or the calcium-binding protein calretinin (CR) (Neddens et al., 2011). 
Microdissection of DLPFC layer 4 yields samples highly enriched in PV relative to CR mRNA, 
which allows an assessment of ErbB4 expression predominantly in PV interneurons (Chung et 
al., 2016b). Moreover, an in situ hybridization assay (See Appendix D; Supplementary 
Methods) demonstrated that layer 4 had the highest PV mRNA levels of any layer in the DLPFC 
and the greatest laminar difference in PV expression between age groups (+46% in post-pubertal; 
t6=-2.6, p=0.042; Fig. 13A). Thus, we micro-dissected DLPFC layer 4 (Fig. 13B) and quantified 
mRNA levels of PV and pan-ErbB4 by qPCR. Consistent with the immunohistochemistry (Fig. 
12A) and the in situ hybridization data (Fig. 13A), PV mRNA levels in layer 4 were significantly 
(t11=-3.4, p=0.006) 57% higher in the post-pubertal (0.071±0.015) relative to the pre-pubertal 
group (0.045±0.012; Fig. 13C). In contrast, pan-ErbB4 mRNA levels in layer 4 did not differ 
between age groups (Pre-pubertal: 0.032±0.011, Post-pubertal: 0.038±0.014; t11=-1.7, p=0.362; 
Fig. 13D). 
We then assessed shifts in ErbB4 splicing between age groups in layer 4. ErbB4 
transcripts are alternatively spliced at two loci (Fig. 13E) (Veikkolainen et al., 2011). Splicing at 
the juxtamembrane (JM) locus produces the minor JM-a variant and the major JM-b variant 
based on the inclusion of exon 16 or 15b, respectively. Inclusion or exclusion of exon 26 at the 
cytoplasmic (CYT) locus yields the minor CYT-1 variant and the major CYT-2 variant, 
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respectively. To investigate shifts in splicing, we assessed the ratio of minor to major splicing 
variant levels at each locus (i.e., JM-a:JM-b ratio and CYT-1:CYT-2 ratio). The JM-a:JM-b ratio 
(Pre-pubertal: 0.073±0.020, Post-pubertal: 0.117±0.048; t11=-3.0, p=0.013; Fig. 13F) and the 
CYT-1:CYT-2 ratio (Pre-pubertal: 0.253±0.090, Post-pubertal: 0.446±0.168; t11=-3.5, p=0.005; 
Fig. 13G) were significantly 62% and 76% higher, respectively, in the post-pubertal group, 
demonstrating a developmental shift in ErbB4 splicing from the major JM-b/CYT-2 to minor 
JM-a/CYT-1 variants during adolescence.  
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Figure 13. Developmental shifts in alternative splicing of ErbB4 transcripts through adolescence in layer 4 of 
monkey DLPFC 
(A) Mean PV mRNA optical density as a function of cortical layer in monkey DLPFC for pre-pubertal (blue) and 
post-pubertal (red) groups. (B) A representative image of a thionin-stained coronal section before and after 
microdissection of layer 4. Layer 4 was identified based on the size and packing density of stained cells. Scale bar = 
100µm. (C,D,F,G) Group mean (bar) and individual monkey (open circles) levels of dependent measures, as 
indicated by the y-axis labels, in DLPFC layer 4. Statistics from student’s t-test for each dependent measures are 
shown above the corresponding graph. (C) Mean PV mRNA levels were significantly higher in the post-pubertal 
group, (D) whereas mean pan-ErbB4 levels did not differ. (E) A schematic diagram depicting the alternative 
splicing loci of ErbB4. (F-G) The JM-a:JM-b variant ratio (E) and the CYT-1:CYT-2 variant ratio (F) were 
significantly higher in the post-pubertal group. 
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4.3.4 Differential regulation of excitatory synapse number on PV interneurons by ErbB4 
splice variants 
To investigate whether ErbB4 major JM-b/CYT-2 and minor JM-a/CYT-1 splice variants 
differentially regulate the number of excitatory synapses on PV interneurons, we transfected 
constructs expressing either ErbB4 JM-a/CYT-1 or JM-b/CYT-2 in rat primary neurons (Fig. 
14A). Each construct bicistronically translates an ErbB4 splice variant and DsRed from a single 
mRNA, so that the intensity of DsRed reflects the levels of the transfected ErbB4 variant. The 
DsRed levels did not differ in PV neurons transfected with each construct (cell body: F2,113=1.5, 
p=0.225; proximal dendrites: F2,113=0.8, p=0.463; Fig. 14B), suggesting that the expression 
levels of these inserts are comparable in PV neurons. Labeling with an anti-ErbB4 antibody 
confirmed the presence of these inserts in transfected neurons (data not shown). The surface 
areas of cell bodies and proximal dendrites did not differ in PV+/DsRed+ neurons transfected 
with each construct (cell body: F2,113=2.2, p=0.115; proximal dendrites: F2,113=0.09, p=0.912; 
Fig. 14C). Overexpression of the JM-b/CYT-2 variant increased the density of VGlut+/PSD95+ 
puncta on the proximal dendrites of PV neurons relative to DsRed controls, whereas JM-a/CYT-
1 overexpression had no discernable effect (F2,113=5.4, p=0.006; Fig. 14D). A similar pattern was 
observed in the cell bodies of PV neurons, although it did not achieve statistical significance 
(F2,113=1.9, p=0.159; Fig. 14D). These findings suggest that the JM-b/CYT-2 variant primarily 
drives the ErbB4 signaling effect on the number of excitatory inputs to PV interneurons, whereas 
the JM-a/CYT-1 variant does not contribute to this effect. 
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Figure 14. Differential regulation of excitatory synapse number on PV interneurons by ErbB4 splice variants 
in rat primary neuronal culture 
(A) Representative images of cultured cortical neurons transfected with either JM-b/CYT-2 variant or JM-a/CYT-1 
variant and labeled with antibodies against PV (blue), DsRed (gray), VGlut1 (green) and PSD95 (red). Transfected 
neurons are labeled with bicistronic DsRed expression. Scale bar = 5µm. Below are the masked images of VGlut1+ 
(green) and PSD95+ (red) puncta within PV dendrites (outlined with dotted lines) from the boxed area. (B-D) Bar 
graphs showing the levels of dependent measures, as indicated by the y-axis labels, in the cell bodies (left) and the 
proximal dendrites (right) of PV+/DsRed+ neurons overexpressing DsRed only (green bar), JM-b/CYT-2 (blue bar) 
or JM-a/CYT-1 (red bar). Data shown are mean percentage (+standard error of mean) from three individual 
experiments normalized to DsRed only (DsRed only: n=37, JM-b/CYT-2: n=43, JM-a/CYT-1: n=36). One-way 
ANOVA statistics for each dependent measures are shown above the corresponding graph. Asterisks indicate p<0.05 
from Tukey’s post-hoc test. 
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4.3.5 Association between ErbB4 splicing shifts and pruning of excitatory synapses on PV 
interneurons in monkey DLPFC 
Finally, in order to investigate whether the differential effects of ErbB4 splice variants on 
the number of excitatory inputs to PV neurons are reflected during pruning in primate DLPFC, 
we assessed the relationships between ErbB4 splicing shifts and the density of excitatory 
synapses on PV interneurons across all monkeys. Previous studies have demonstrated that ErbB4 
signaling regulates the formation of excitatory synapses on PV interneurons primarily by its 
effect on synaptic recruitment of PSD95 (Huang et al., 2000; Ting et al., 2011; Seshadri et al., 
2015). Consistent with these findings, the JM-a:JM-b (R=-0.612, p=0.026) and CYT-1:CYT-2 
(R=-0.642, p=0.018) ratios were both significantly negatively correlated with the mean density 
of PSD95+ puncta on PV cell bodies across all animals. 
4.4 DISCUSSION 
In this study, we tested the hypotheses that excitatory synapses on cortical PV 
interneurons are pruned during adolescence and this pruning process is attributable to shifts in 
ErbB4 expression and/or splicing. In layer 4 of monkey DLPFC, the density of 
VGlut1+/PSD95+ puncta on PV neurons was lower in post-pubertal relative to pre-pubertal 
monkeys, demonstrating that excitatory synapses on cortical PV interneurons undergo pruning 
through adolescence. Moreover, although pan-ErbB4 mRNA levels did not differ between age 
groups, the JM-a:JM-b and CYT-1:CYT-2 variant ratios were higher in post-pubertal monkeys. 
Furthermore, these ratios were negatively correlated with the density of PSD95+ puncta on PV 
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neurons across all animals; these findings suggest that pruning of excitatory synapses on cortical 
PV interneurons might be regulated by developmental shifts in ErbB4 splicing. This 
interpretation was supported by findings that overexpression of JM-b/CYT-2 variant increased 
the density of VGlut1+/PSD95+ puncta on the proximal dendrites of PV neurons, whereas 
overexpression of JM-a/CYT-1 variant had no effects. 
Our findings indicate that PV protein levels increase in association with the pruning of 
excitatory synapses on PV interneurons in primate DLPFC. These results might seem 
contradictory with prior findings that 1) PV expression is activity-dependent (Behrens et al., 
2007; Belforte et al., 2010; Del Pino et al., 2013), and 2) the density of excitatory synapses on 
PV neurons positively predicts PV immunoreactivity levels in mouse hippocampus (Donato et 
al., 2013) and human DLPFC (Chung et al., 2016a). However, we also found that the excitatory 
synapses remaining after pruning have higher levels of VGlut1 and PSD95 proteins. Higher 
levels of VGlut1 and PSD95 have been shown to increase the amplitude of excitatory 
postsynaptic currents and to correlate with the maturation of excitatory synapses (El-Husseini et 
al., 2000; Wilson et al., 2005). Consequently, the excitatory synapses on PV interneurons that 
remain after pruning likely represent mature synaptic connections with stronger excitatory 
neurotransmission. Therefore, our findings suggest that the maturation of excitatory synaptic 
inputs to PV interneurons during adolescence involves a reduction in the total number of 
synapses and a strengthening of the remaining synapses. More refined and mature glutamatergic 
inputs to PV interneurons could support more precise excitation of these neurons during gamma 
oscillations and consequently contribute to the improvement of working memory function during 
adolescence. 
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Our results demonstrate that the transcription of ErbB4 does not change with age, but that 
shifts in ErbB4 splicing from the JM-b/CYT-2 to JM-a/CYT-1 variants occur in PV interneurons 
during adolescence in primate DLPFC. The ErbB4 signaling pathway has been associated with 
multiple aspects of neuronal development (Mei and Xiong, 2008), including the positive 
modulation of excitatory synapse number on PV interneurons (Rico and Marin, 2011; Mei and 
Nave, 2014). Similar to other genes that are involved in neurodevelopment (Norris and Calarco, 
2012), the functional consequence of ErbB4 signaling in PV neurons could be modulated by 
alternative splicing of ErbB4 transcripts. For example, our study demonstrates that the JM-
b/CYT-2 variant increases the number of excitatory synapses on PV interneurons, whereas the 
JM-a/CYT-1 variant has no effects. These data suggest that normal ErbB4 signaling in PV 
neurons is mainly mediated by the major JM-b/CYT-2 variant, whereas the JM-a/CYT-1 variant 
serves as an inactive form of ErbB4. Consequently, shifts in ErbB4 splicing from the normal JM-
b/CYT-2 variant to the inactive JM-a/CYT-1 variant could collectively result in a loss of ErbB4 
signaling, which has been shown to reduce the number of excitatory synapses on PV 
interneurons (Ting et al., 2011; Del Pino et al., 2013). In support of this idea, we found that the 
density of PSD95+ puncta on PV interneurons was negatively correlated with the JM-a:JM-b and 
CYT-1:CYT-2 variants ratios across all animals. Thus, our findings suggest that developmental 
shifts in ErbB4 splicing could function as a molecular switch triggering the pruning of excitatory 
synapses on PV interneurons during adolescence. 
Existing data suggest that the JM-a/CYT-1 variant might inactivate normal ErbB4 signaling, 
and thus contribute to the pruning of excitatory synapses on PV interneurons, through the 
following mechanisms. The JM-a variant, unlike the JM-b variant, contains the juxtamembrane 
domain that is susceptible to multiple cleavages, generating soluble extracellular and intracellular 
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truncated peptides (Rio et al., 2000; Ni et al., 2001). The extracellular peptide could 
competitively block the binding of ErbB4 ligand neuregulin-1 and inhibit normal ErbB4 
signaling. Moreover, the intracellular peptide contains both the PDZ-binding and kinase motifs 
of ErbB4 (Maatta et al., 2006; Sundvall et al., 2010), both of which are necessary to induce 
stable synaptic localization of PSD-95 (Garcia et al., 2000; Huang et al., 2000; Ting et al., 2011). 
Upon cleavage, the intracellular peptides are displaced to the nucleus (Sardi et al., 2006), which 
would result in a loss of interaction between ErbB4 and PSD-95 at the synapse, and subsequent 
pruning of excitatory synapses on PV interneurons. Finally, unlike the CYT-2 variant, the CYT-1 
variant contains a binding site for Nedd4, an E3 ubiquitin ligase (Zeng et al., 2009). Binding of 
Nedd4 to CYT-1 results in an increased ubiquitination and a subsequent degradation of ErbB4, 
which could also contribute to a decrease in ErbB4 signaling and loss of synapses. 
Other molecules that converge onto ErbB4 signaling pathway could also participate in the 
pruning of excitatory synapses on PV interneurons (Jaaro-Peled et al., 2009). For example, 
Disrupted-in-schizophrenia 1 (DISC1) can interfere with the interaction between ErbB4 and 
PSD95, resulting in an inhibition of ErbB4 signaling in GABAergic interneurons (Seshadri et al., 
2015). Similar to ErbB4, alternative splicing of the DISC1 transcript is developmentally 
regulated and may modulate the functional consequences of DISC1 signaling pathway (Nakata et 
al., 2009). Thus, if shifts in DISC1 expression and/or splicing occur in PV interneurons during 
adolescence, DISC1 could trigger the pruning of excitatory synapses on these neurons 
synergistically with the developmental changes in ErbB4 splicing.  
Several methodological issues are important to consider in interpreting the results of this 
study. First, our sampling of excitatory synapses excluded the VGlut2-containing thalamo-
cortical excitatory synapses (Fremeau et al., 2001). However, previous EM studies demonstrated 
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that thalamic excitatory inputs represent only ~10% of total excitatory synapses in the cortex 
(Latawiec et al., 2000) and only a small percentage (~2%) of thalamic inputs innervate PV 
interneurons (Rotaru et al., 2005). Second, we excluded sampling of synapses on the dendrites of 
PV interneurons in monkey DLPFC due to the lack of PV immunoreactivity within these 
structures. Although PV neurons receive excitatory inputs more frequently on their dendrites 
than cell bodies (Hioki, 2015), somal excitatory inputs produce much stronger depolarization in 
PV neurons than dendritic excitatory inputs (Hu et al., 2010; Norenberg et al., 2010). Moreover, 
the densities of excitatory inputs to the dendrites (Donato et al., 2013) and the cell bodies (Chung 
et al., 2016a) of PV neurons both similarly predict activity-dependent PV levels. Thus, these 
findings suggest that our sampling approach sufficiently captures functionally important 
excitatory synapses on PV interneurons. 
In conclusion, our study demonstrates a previously unrecognized role of synaptic pruning in 
the maturation of excitatory synapses on cortical PV interneurons during adolescence that is 
mediated by a shift in ErbB4 splicing. Deficits in cortical PV interneuron maturation have been 
linked to several neuropsychiatric disorders including schizophrenia (Lewis et al., 2012). In the 
DLFPC of individuals with schizophrenia, a pathogenic shift in ErbB4 splicing from the JM-b to 
JM-a variants has been associated with fewer excitatory synaptic inputs to PV interneurons 
(Chung et al., 2016a; Chung et al., 2016b), which could reflect an exaggerated pruning process in 
these neurons. Therefore, findings from our study support the view that schizophrenia is a 
neurodevelopmental disorder with disturbances in the normal maturation process of prefrontal 
inhibitory circuits (Lewis et al., 2004). 
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5.0  GENERAL DISCUSSION 
5.1 SUMMARY OF FINDINGS 
In this dissertation, I provided evidence for perturbations of certain transcriptional, 
molecular and synaptic elements of prefrontal cortical circuitry in schizophrenia and their 
contribution to PV interneuron maturation during adolescence. In this section, I will summarize 
findings from each chapter and then consider how these findings could support the disease model 
I presented in the general introduction section.  
In chapter 2, I investigated dysregulated ErbB4 splicing in schizophrenia and its 
selective effect on PV expression. Levels of JM-a and CYT-1 variants were higher and levels of 
JM-b and CYT-2 variants were lower selectively in layer 4, where PV neurons are enriched, but 
not in layer 2, where CR neurons are enriched, in the DLPFC of schizophrenia subjects relative 
to comparison subjects. Moreover, the JM-a:JM-b variant ratio was negatively correlated with 
PV mRNA levels selectively in layer 4 of schizophrenia subjects. Finally, MIAT levels were 
higher preferentially in PV interneurons in subjects with schizophrenia. This evidence supports 
the hypotheses that 1) schizophrenia is associated with abnormal shifts in ErbB4 splicing from 
the JM-b/CYT-2 to JM-a/CYT-1 variants selectively in PV but not in CR interneurons; 2) 
dysregulated ErbB4 splicing at the JM locus is associated with lower PV mRNA levels in 
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schizophrenia; and 3) higher MIAT level is associated with dysregulated ErbB4 splicing in 
schizophrenia. 
In chapter 3, I investigated pathological basis for deficient excitatory drive to PV 
interneurons in schizophrenia and the contribution of ErbB4 splicing in this process. The density 
of excitatory synaptic inputs to PV but not CR interneurons was lower in the DLPFC of 
schizophrenia subjects. Furthermore, fewer excitatory synapses on PV interneurons predicted 
lower levels of activity-dependent PV and GAD67 levels selectively in schizophrenia subjects. 
Finally, dysregulated ErbB4 splicing at the JM locus predicted fewer excitatory synapses on PV 
interneurons in schizophrenia subjects. These findings support the hypotheses that 1) 
schizophrenia is associated with a loss of excitatory synapses on PV interneurons; 2) deficits in 
excitatory synaptic inputs to PV interneurons predict reduced PV interneuron activity; and 3) 
dysregulated ErbB4 splicing may contribute to fewer excitatory synapses on PV interneurons in 
schizophrenia. 
In chapter 4, I investigated developmental pruning of excitatory synapses on PV 
interneurons in postnatal monkeys and the contribution of ErbB4 splicing to this process. The 
density of excitatory synaptic inputs to PV interneurons was lower in the DLPFC of post-
pubertal monkeys relative to pre-pubertal monkeys. The excitatory synapses remaining on PV 
neurons after pruning contained higher levels of VGlut1 and PSD95 proteins. Moreover, shifts in 
ErbB4 splicing at the JM and the CYT loci predicted a lower density of excitatory synapses on 
PV interneurons across all animals. Finally, overexpression of the ErbB4 JM-b/CYT-2 variant in 
primary neuronal cultures increased, whereas JM-a/CYT-1 had no effect on the number of 
excitatory synapses on PV interneurons. These findings support the hypotheses that 1) excitatory 
synapses on PV interneurons are pruned during adolescence and the remaining synapses are 
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strengthened; 2) this developmental pruning is associated with shifts in alternative splicing of 
ErbB4 in PV interneurons; and 3) the ErbB4 JM-a/CYT-1 variant does not contribute to the 
normal effect of ErbB4 signaling. Thus, ErbB4 splicing shifts from the JM-b/CYT-2 to JM-
a/CYT-1 could be associated with the loss of ErbB4 signaling and consequently fewer excitatory 
synaptic inputs to PV interneurons. 
In concert, these findings from primary neuronal culture, postnatal monkeys and human 
subjects support the hypothesis proposed in the introductory model that developmental shifts in 
ErbB4 splicing contribute to the pruning of excitatory synaptic inputs to PV interneurons and 
that disturbances in this process could induce fewer excitatory synapses onto, and consequently 
reduced activity of, PV interneurons in schizophrenia (Figure 15). Findings from my dissertation 
collectively suggest that for a given individual, a shift in ErbB4 splicing from the JM-b/CYT-2 to 
JM-a/CYT-1 splice variant occurs in PV interneurons during adolescence. This splicing shift 
results in a mild loss of ErbB4 signaling, which in turn triggers the pruning of superfluous 
excitatory synapses on PV interneurons. In schizophrenia, the ErbB4 splicing shift is 
dysregulated and results in abnormally high levels of the JM-a/CYT-1 variant and low levels of 
the JM-b/CYT-2 variant. This molecular shift leads to a pathological impairment in ErbB4 
signaling and an exaggerated pruning process, resulting in a loss of normal excitatory synapses 
on PV interneurons. In the following sections I will discuss the potential implications of the 
ErbB4 splicing shifts and pruning of excitatory inputs to PV interneurons in cortical circuitry 
maturation and schizophrenia. 
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Figure 15. Proposed role of ErbB4 splicing shifts in regulating the number of excitatory synaptic inputs to PV 
interneurons in development and schizophrenia 
(A) Data points compiled from studies in chapters 2 and 3 representing the relationship between the JM-a:JM-b 
splice variant ratio and the density of VGlut1+/PSD95+ puncta on PV+ cell bodies across postnatal monkeys, 
unaffected comparison subjects and schizophrenia subjects. The data points from postnatal monkeys were 
normalized to the mean of the post-pubertal group, whereas the data points from human subjects were normalized to 
the mean of the comparison group. (B) In postnatal development, a shift in ErbB4 splicing from the normal JM-
b/CYT-2 to inactive JM-a/CYT-1 splice variants occurs in PV interneurons. This splicing shift results in a mild loss 
of ErbB4 signaling, which triggers the pruning of superfluous excitatory synapses on PV interneurons. In 
schizophrenia, the ErbB4 splicing shift is dysregulated and results in abnormally high levels of inactive JM-a/CYT-1 
variant and low levels of normal JM-b/CYT-2 variant. This in turn induces a pathogenic loss of ErbB4 signaling and 
an exaggerated pruning process, resulting in a loss of normal excitatory synapses on PV interneurons. 
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5.2 IMPLICATIONS IN CORTICAL CIRCUITRY MATURATION AND 
SCHIZOPHRENIA 
Our findings introduce a potential mechanism that allows PV interneurons to regulate 
their excitatory synapse density in response to changes in neuronal activity. A recent study 
identified a non-coding RNA MIAT that modulates alternative splicing of ErbB4 pre-mRNA in 
an activity-dependent manner (Barry et al., 2014). This study demonstrated that MIAT normally 
sequestered splicing factors such as QKI and SRSF1, restricting their access to ErbB4 pre-
mRNA. Upon neuronal activation, the expression level of MIAT was reduced, presumably 
resulting in a release of splicing factors to ErbB4 pre-mRNA. Moreover, a knock down of MIAT 
in human induced pluripotent stem cell derived neuronal culture led to higher levels of ErbB4 
JM-a and CYT-1 variants. This phenotype reflects the changes we observed in PV interneurons 
in schizophrenia (Figure 4). Finally, the expression levels of MIAT were shown to be reduced in 
the superior temporal gyrus of subjects with schizophrenia. Thus, findings from this study 
suggest that activity-dependent expression of MIAT regulates the alternative splicing of ErbB4 
transcripts and deficits in MIAT levels in schizophrenia induces dysregulated ErbB4 splicing. 
However, data from this study should be interpreted with caution. For example, this 
study found lower levels of MIAT in the superior temporal gyrus of schizophrenia subjects 
whereas our study detected higher levels of MIAT in the DLPFC of subjects with schizophrenia; 
such a discrepancy might come from differences in the human cohorts and the brain regions from 
which the MIAT levels were quantified. Nevertheless, as the neuronal activity is thought to be 
dampened in schizophrenia (Driesen et al., 2008) and the expression of MIAT is shown to be 
inhibited by neuronal activity in an experimental system, the expression level of MIAT is 
expected to be higher in schizophrenia. Moreover, the primer pairs used in Barry et al to detect 
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ErbB4 splice variants in the MIAT knock-down assay seem to non-specifically detect other 
ErbB4 variants. Therefore, although this study has identified a splicing regulator MIAT that is 
expressed in an activity-dependent manner, it lacked the proper resolution to determine how 
MIAT directly affects the alternative splicing of ErbB4 transcripts. 
Despite these limitations in interpreting the data from Barry et al, the hypothesis that 
ErbB4 splicing is regulated by neuronal activity is intriguing, since such a mechanism could 
provide PV interneurons with the machinery that triggers the developmental pruning of 
superfluous excitatory synaptic inputs in response to the maturation of functionally-relevant 
synaptic connections with pyramidal neurons. Moreover, in mature neuronal circuits, this 
mechanism could be utilized to maintain excitation/inhibition (E/I) balance by re-adjusting the 
number of excitatory inputs to PV interneurons and consequently PV-mediated inhibition in 
response to changes in pyramidal neuron activity. ErbB4 splicing shifts are unlikely to be the 
only means by which neuronal activity participates in this process, as the alternative splicing of 
ErbB4 ligand neuregulin-1 (Nrg-1) is also regulated in an activity-dependent manner (Liu et al., 
2011). Thus, neuronal activity seems to orchestrate the effect of Nrg-1/ErbB4 signaling by 
modulating the alternative splicing of both ligand and the receptor. Nevertheless, because 
functional consequences of different Nrg-1 isoforms are not clear in PV interneurons, I will 
solely focus on the effect of neuronal activity in regulating ErbB4 splicing shifts. 
Our data demonstrate that the activity-dependent PV expression levels and ErbB4 
splicing shifts are correlated positively during postnatal development and negatively in 
schizophrenia. These findings would argue paradoxically that the ErbB4 splicing shift from the 
JM-b/CYT-2 to JM-a/CYT-1 variants is induced by increasing neuronal activity during 
development, but in schizophrenia reduced neuronal activity triggers this splicing shift. In order 
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to explain the opposing relationship between PV interneuron activity and ErbB4 splicing shifts in 
development and disease, I propose the “developmental arrest model” (Figure 16). In this model, 
the splicing shift from the JM-b/CYT-2 to JM-a/CYT-1 variant is induced by a splicing factor 1 
(Factor 1) and inhibited by a splicing factor 2 (Factor 2), which are both expressed in PV 
interneurons. The promotors of Factor 1 and Factor 2 are both activated by neuronal activity but 
the Factor 2 promotor is activated only by high neuronal activity. 
 
Figure 16. Developmental arrest model for activity-dependent regulation of ErbB4 splicing shifts 
(A) Hypothetical activity-dependent signaling pathway that leads to pruning of excitatory inputs to PV neurons. 
Findings from this dissertation suggest that shifts in ErbB4 splicing from the JM-b/CYT-2 to JM-a/CYT-1 variants 
result in a loss of ErbB4 signaling and pruning of excitatory synapses on PV neurons. This model introduces an 
activity-regulated “factor 1” and “factor 2” that induces or inhibits, respectively, shifts in ErbB4 splicing to the JM-
a/CYT-1 variant. (B) In this model, the expression of factor 1 is induced in PV interneurons by increasing neuronal 
activity during postnatal development. Factor 1 induces ErbB4 splicing shifts and initiates pruning of excitatory 
inputs to PV neurons. Into early adulthood, the neuronal activity of mature PV interneuron induces the expression of 
Factor 2, which inhibits the shifts in ErbB4 splicing and stops the pruning process. Therefore, the sensitive period 
for the maturation of excitatory inputs to PV interneuron would be based upon changes in the ratio of factor 1 to 
factor 2 expression levels, which defines the onset and the closure of the pruning process. In schizophrenia, PV 
interneuron activity does not reach the adult level, resulting in a failure to establish closure of the sensitive period. 
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In this model, developmental strengthening of the functionally-relevant synaptic 
connections between pyramidal neurons and PV interneurons increases PV interneuron activity, 
as evidenced by a robust increase in activity-dependent PV expression early in human postnatal 
development (Fung et al., 2010). Increasing PV interneuron activity activates the expression of 
Factor 1 and induces a shift in ErbB4 splicing from JM-b/CYT-2 to JM-a/CYT-1 variants. This 
splicing shift triggers an elimination of superfluous and non-relevant synaptic connections in PV 
interneurons during adolescence. Into early adulthood, the neuronal activity of mature PV 
interneurons induces the expression of Factor 2, which inhibits the shifts in ErbB4 splicing and 
the pruning process. The balance between expression levels of Factor 1 and Factor 2 would allow 
PV interneurons to achieve an optimal level of excitatory synaptic number in adulthood. Thus, 
the onset and the closure of sensitive period for proper pruning of excitatory inputs to PV 
interneuron would be defined by the initiation and the termination of ErbB4 splicing shifts, 
respectively. 
In schizophrenia, previous studies have shown that for most GABA-related transcripts, 
including PV mRNA, the changes in expression level with postnatal development were in the 
opposite direction of the differences observed between schizophrenia and comparison subjects 
(Fung et al., 2010; Hoftman et al., 2015). Based on this observation, it was proposed that the 
developmental trajectory of prefrontal inhibition is blunted and does not reach the adult level in 
schizophrenia (Hoftman et al., 2015). Therefore, if PV interneuron activity does not reach the 
mature level and is arrested at an earlier developmental stage, presumably at the adolescent 
period, this in turn would fail to induce the expression of Factor 2, resulting in a persistently 
predominant expression of Factor 1. Failure to achieve the balance between Factor 1 and Factor 
2 expression levels would result in a continued shifting of ErbB4 splicing to JM-a/CYT-1 
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variants, causing a pathological elimination of mature excitatory synapses on PV interneurons. 
Consequently, the loss of excitatory inputs to and reduced activity of PV interneurons in 
schizophrenia might be the result of a failure to establish the closure of sensitive period during 
adolescence. In section 5.4, I will discuss potential experiments that can test the validity of this 
model. 
I would like to emphasize that Factors 1 and 2 in this model are hypothetical molecules 
based on the interpretation of the existing data, but a similar activity-dependent mechanism does 
exist for regulating the alternative splicing of Neurexin-1 transcripts. Neurexin-1 is an autism 
susceptibility gene that participates in the formation of excitatory synapses (Craig and Kang, 
2007). At moderate neuronal activity, alternative splicing of Neurexin-1 transcripts is shifted 
towards the Neurexin-1 4(+) variant that includes exon 20, which favors synaptic formation 
(Uemura et al., 2010). High neuronal activity activates the RNA binding protein SAM68, which 
inhibits an inclusion of exon 20 (Iijima et al., 2011). This renders Neurexin-1 to have a stronger 
interaction with its receptor neuroligin-1B thereby stabilizing the synaptic connections. 
In the following sub-sections, I will first review some of the putative causal factors that 
might arrest the maturation of PV interneuron activity in schizophrenia, and then I will provide 
potential implications of the developmental arrest model that could explain the relationship 
between such causal factors and ErbB4 splicing shifts. The term “reduced PV interneuron 
activity” as used here indicates a lower level of PV interneuron activity (due to developmental 
arrest; see boundary defined by the two dotted vertical lines in Figure 2B), that is sufficient to 
induce the factor 1 but not enough to express the factor 2. This notion is supported by findings 
that PV mRNA expression levels in schizophrenia subjects are greater than those found in 
 85 
normal neonates and infants but less than those found in adult comparison subjects (Fung et al., 
2010). 
5.2.1 Perineuronal net disruption 
Alterations in perineuronal net (PNN) formation could reduce the activity of PV 
interneurons and might function as an upstream cause for abnormal ErbB4 splicing shifts in 
schizophrenia. PNNs are aggregates of extracellular matrix that preferentially encapsulate the 
proximal neurites and cell body of PV interneurons (Berretta et al., 2015). During postnatal 
development, PNNs stabilize synaptic connections and restrict synaptic plasticity (Dityatev and 
Schachner, 2003). Moreover, disrupting PNNs reduces AMPA receptor clustering and excitatory 
drive to PV interneurons, induces a disinhibition of pyramidal neurons and produces abnormal 
gamma oscillations in animal models (Chang et al., 2010; Shah and Lodge, 2013; Steullet et al., 
2014). In human DLFPC, the number of PNN-positive PV interneurons increases during 
adolescence and the intensity levels of extracellular matrix within PNNs are reduced in the 
DLFPC of individuals with schizophrenia (Mauney et al., 2013; Enwright et al., 2016). Finally, 
schizophrenia-associated redox dysregulation and oxidative stress (Emiliani et al., 2014), which 
are known to impair PV interneuron activity (Cabungcal et al., 2014), also disrupt PNN 
formation (Cabungcal et al., 2013a). Thus, dysregulated PNN formation during adolescence in 
schizophrenia could trigger an initial reduction in excitatory drive to PV neurons, which in turn 
induces abnormal ErbB4 splicing shifts and further loss of excitatory inputs to these neurons. 
While these data suggest the role of PNN disruption in the pathogenesis of schizophrenia, 
it is important to note that in the human DLPFC, PNNs are localized primarily in layers 3 and 5 
but virtually absent in layer 4 (Mauney et al., 2013), where PV neurons are predominantly 
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localized (Figure 13A). Consequently, laminar PNN deficits in schizophrenia seem to be more 
pronounced in cortical layers 3 and 5 whereas the loss of PNN is not observed in layer 4 
(Mauney et al., 2013). In contrast to this data, the greatest deficit in PV expression is observed in 
cortical layer 4 of schizophrenia (Hashimoto et al., 2003). Thus, although it is possible that PNN 
disruptions may influence the activity of some PV interneurons in cortical layers 3 and 5, it is 
unlikely that they contribute to the activity regulation in majority of PV neurons in 
schizophrenia. Alternatively, based on the existing data, it would be more plausible to 
hypothesize that the absence of PNN in DLPFC layer 4 renders PV neurons in this layer 
preferentially vulnerable to oxidative stress and redox dysregulation. Consequently, these 
neurons would be affected to a greater degree in schizophrenia than PV interneurons in other 
cortical layers. Consistent with this idea, chronic redox dysregulation that produces oxidative 
stress has been shown to preferentially affect PV interneurons without PNNs in an animal model 
(Cabungcal et al., 2013b). 
5.2.2 NMDAR hypofunction 
Reduced PV interneuron activity in schizophrenia could be a consequence of hypoactive 
N-methyl-D-aspartate receptors (NMDAR) in these neurons. Studies in animal models show that 
systemic administration of NMDAR antagonists decreases PV and GAD67 expression levels and 
disinhibits pyramidal cell firing (Behrens et al., 2007; Homayoun and Moghaddam, 2007). Also, 
an early postnatal knockout of NMDAR core subunit NR1 in GABAergic interneurons results in 
reduced PV and GAD67 expression levels, abnormal gamma oscillations and behavioral deficits 
that are associated with schizophrenia (Belforte et al., 2010). Consistent with these data, 
administration of NMDAR antagonists, such as phencyclidine and ketamine, have been shown to 
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transiently reproduce full range of symptoms associated with schizophrenia in human subjects 
(Krystal et al., 1994; Coyle et al., 2012). Taken together, these multiple lines of evidence suggest 
that deficits in NMDAR function in PV interneurons might serve as an upstream casual factor for 
dysregulated ErbB4 splicing.  
Nevertheless, recent studies demonstrate that the excitation of PV interneurons is driven 
predominantly by calcium permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor (AMPAR) with a minimal contribution from NMDAR (Wang and Gao, 2009; Rotaru et 
al., 2011). Consistent with this notion, a PV-specific NR1 knockout does not recapitulate many 
of the schizophrenia-associated deficits seen in an animal model with interneuron-specific NR1 
knockout (Korotkova et al., 2010; Saunders et al., 2013). In contrast to the medial ganglionic 
eminence-derived neurons including PV neurons, the excitation of caudal ganglionic eminence-
derived interneuron subtypes, such as those containing vasoactive intestinal peptide (VIP), is 
mainly driven by NMDAR (Matta et al., 2013). Interestingly, VIP interneurons have been shown 
to disinhibit the activity of PV neurons by providing inhibitory inputs to somatostatin (SST) 
neurons that normally inhibit PV neurons (Pfeffer et al., 2013; Pi et al., 2013). Thus, reduced PV 
neuron activity due to the interneuron-specific NR1 knockout as mentioned above could be a 
consequence of hypoactive NMDAR in VIP neurons, which would increase the inhibitory effect 
of SST neurons on PV neurons. However, as these data are solely from rodent models, it is 
critical to investigate whether the selective enrichment of AMPAR and NMDAR in different 
interneuron subtypes is conserved in the primate DLPFC. 
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5.2.3 Dendritic spine deficits 
Reduced PV neuron activity in schizophrenia could be a consequence of deficits in 
dendritic spines and hypoactive pyramidal neurons. Dendritic spines are morphologically and 
biochemically discrete synaptic compartments that protrude from the dendritic shafts of cortical 
pyramidal neurons and are the site of most excitatory synapses in the cortex (DeFelipe and 
Farinas, 1992). Reduced density of dendritic spines in layer deep 3 (L3D) pyramidal neurons has 
been consistently replicated in the DLPFC of schizophrenia (Garey et al., 1998; Glantz and 
Lewis, 2000; Konopaske et al., 2014). This deficit seems to be a cell type-specific and DLPFC-
prominent pathology as spine density is not lower in layer 5 pyramidal neurons or in layer 3 
pyramidal neurons in the primary visual cortex. Moreover, the levels of gene products that are 
associated with CDC42 pathway, which normally participates in dendritic spine formation, have 
been shown to be altered in L3D pyramidal neurons in subjects with schizophrenia (Hill et al., 
2006; Ide and Lewis, 2010; Datta et al., 2015). Finally, de novo mutations and common alleles 
that are associated with schizophrenia were shown to be enriched for genes that are involved in 
dendritic spine formation and glutamatergic neurotransmission (Fromer et al., 2014; 
Schizophrenia Working Group of the Psychiatric Genomics, 2014). These data collectively 
demonstrate that schizophrenia is associated with dendritic spine deficits and hypoactive L3D 
pyramidal neurons.  
PV interneurons receive excitatory inputs primarily from local pyramidal neurons 
(Thomson and Lamy, 2007). The strength of excitatory inputs to cortical layer 4 PV neurons 
from local pyramidal neurons is likely to be reduced in the illness because these pyramidal 
neurons are thought to be less active due to deficits in their dendritic spines (Lewis et al., 2012; 
Arion et al., 2015). In schizophrenia, a consequence of reduced excitatory inputs from 
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hypoactive pyramidal neurons may involve dysregulated ErbB4 splicing in PV interneurons, 
which would trigger a further reduction of excitatory inputs to and the activity of PV 
interneurons in order to decrease feedback inhibition to pyramidal neurons. This process could 
restore the excitation/inhibition (E/I) balance in the DLPFC circuitry of schizophrenia that is 
initially disrupted by hypoactive pyramidal neurons. Consistent with this idea, the loss of ErbB4 
signaling in PV interneurons results in a lower number of perisomatic inhibitory inputs to and 
reduced inhibitory transmission in pyramidal neurons (Woo et al., 2007; Fazzari et al., 2010).  
The maturation of dendritic spines involves pruning of superfluous spines and 
strengthening of remaining spines, both of which seem to be regulated by neuronal activity 
(Huttenlocher, 1979; Bourgeois et al., 1994; Anderson et al., 1995; Segal et al., 2000; Gonzalez-
Burgos et al., 2008; Petanjek et al., 2011; Bian et al., 2015). These findings suggest that the 
maturation processes of both dendritic spines and excitatory inputs to PV neurons might involve 
1) activity-dependent regulation, 2) pruning of synapses and 3) strengthening of the remaining 
synapses. Such similarities raise three important speculations regarding how they might 
contribute to maintaining E/I balance in development and schizophrenia. First, during postnatal 
development, the maturation processes of dendritic spines and excitatory inputs to PV 
interneurons might induce each other by activity-dependent regulation in order to maintain the 
E/I balance within DLPFC circuitry. This notion is supported by the temporal overlap between 
pruning processes of dendritic spines and of excitatory inputs to PV neurons over adolescent 
period in the primate DLPFC (Anderson et al., 1995) (Figure 11A). Second, at least our findings 
in chapter 3 suggest that the schizophrenia-associated changes in excitatory inputs to PV neurons 
involve fewer number of synapses without strengthening of remaining synapses. Although there 
is currently no direct evidence, we can also speculate that the dendritic spine deficits in 
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schizophrenia is not accompanied by strengthening of remaining spines, since pyramidal neurons 
in the illness seem to be hypoactive (Arion et al., 2015). Thus, the changes in excitatory synapses 
to pyramidal and PV neurons in schizophrenia, unlike in development, might only involve a 
reduction in the number without affecting the strength of synapses, which collectively would 
result in reduced excitatory drive to each cell type. Finally, the above two speculations converge 
onto the hypothesis that the pathogenic loss of excitatory inputs to either pyramidal neurons or 
PV interneurons in schizophrenia could trigger over-pruning of excitatory inputs to the other 
neuron through activity-dependent regulation in order to restore E/I balance (see Figure 17 for 
further explanation).  
 
Figure 17. Proposed E/I balance adjustment by activity-dependent synaptic pruning in response to deficits in 
either pyramidal (top) or PV neurons (bottom) in schizophrenia 
Each image shows a simple neural circuit composed of a pyramidal neuron (blue) and a PV neuron (yellow) 
connected to each other (Pyr-PV neural circuit). Top: 1) Cell autonomous dendritic spine deficits result in a 
hypoactive pyramidal neuron. 2) Hypoactive pyramidal neuron sends reduced glutamatergic drive to a PV neuron 
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which in turn triggers ErbB4 splicing shifts and compensatory downregulation of excitatory synapses on PV neuron. 
3) PV neuron with reduced activity sends lower feedback inhibition to pyramidal neuron. Bottom: 1) Cell 
autonomous deficits in PV neuron activity triggers ErbB4 splicing shifts, which in turn results in a loss of excitatory 
inputs to PV neuron. 2) A hypoactive PV neuron sends reduced inhibitory drive to pyramidal neuron. 3) Disinhibited 
pyramidal neuron triggers activity-dependent dendritic spine pruning that results in compensatory downregulation of 
pyramidal neuron activity. 
 
Although in this section I hypothesized that the over-pruning of excitatory inputs to PV 
neurons is a compensatory response to the upstream dendritic spine deficits, some unknown PV-
specific etiological factors could induce dysregulated ErbB4 splicing and a reduction in the 
number of excitatory inputs to PV interneurons. Then, in this event the loss or over-pruning of 
dendritic spines would function as a homeostatic mechanism that reduces pyramidal neuron 
activity in response to reduced inhibition from PV interneurons. Consistent with this idea, 
impairing glutamatergic drive to PV interneurons by knocking out ErbB4 in these neurons has 
been shown to reduce the density of dendritic spines in animal models (Del Pino et al., 2013; Yin 
et al., 2013a).  
The end result of either event, in which the dendritic spine deficit or the loss of excitatory 
inputs to PV neurons provides an upstream cause, would both reflect the DLPFC circuitry 
alterations seen in schizophrenia (Figure 17). Nevertheless, determining which cell type, 
pyramidal neurons or PV neurons, provides the upstream cause in the disease is not only 
important for deciding where the dysregulated ErbB4 splicing might fit in the pathogenesis of 
schizophrenia, but also critical for developing new therapeutic strategies. There are a number of 
limitations to using animal studies to directly address this question, since an isolated disruption 
in either excitatory activity (Han et al., 2013) or inhibitory activity (Del Pino et al., 2013; Yin et 
al., 2013a) causes disruptions in the other system in order to maintain E/I balance. Although such 
studies could elucidate basic mechanisms by which neural circuit maintains E/I balance, these 
studies may not tell us which side of E/I disruption is the upstream cause in schizophrenia.  
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Given that the pathology of schizophrenia is thought to reflect a disruption in normal 
developmental processes of prefrontal cortical circuitry (Lewis, 1997), perhaps we may need to 
take a step back and first understand how the maturation processes of dendritic spines and 
excitatory inputs to PV neurons might contribute to triggering each other during normal 
development in the primate DLPFC. For example, if the onset of spine pruning precedes that of 
pruning of excitatory inputs to PV neurons during postnatal development, this finding would 
suggest that the maturation of dendritic spines and increased pyramidal neuron activity trigger 
the downstream activity-dependent maturation of excitatory inputs to PV neurons. This in turn 
would provide a greater feedback inhibition to the mature pyramidal neurons. Thus, this finding 
would support the hypothesis that the directionality of normal E/I balance adjustment during 
development is from pyramidal neurons to PV interneurons. The opposite would be supported by 
the findings that the pruning of excitatory inputs to PV neurons precedes the dendritic spine 
pruning during postnatal development. PV interneurons receive inputs predominantly from local 
pyramidal neurons (Lee et al., 2013), whereas the source of excitatory inputs to DLPFC 
pyramidal neurons include intrinsic as well as cortical and subcortical areas that mature earlier 
than DLPFC (Kritzer and Goldman-Rakic, 1995; Melchitzky et al., 1999). Therefore, it is likely 
that the maturation processes of dendritic spines and excitatory inputs to PV neurons initiate at 
different developmental time points. In section 5.4 I will introduce potential experiments that can 
test the validity of this model. 
In this section, I discussed the potential role of ErbB4 splicing shifts and pruning of 
excitatory inputs to PV neurons in cortical circuitry maturation and schizophrenia. In the next 
section, I will expand upon the implication of my findings in the context of working memory 
function using the basic mechanisms discussed in this section in order to speculate how ErbB4 
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splicing shifts and pruning of excitatory inputs to PV neurons could be associated with working 
memory maturation and how alterations in these processes may result in working memory 
deficits in schizophrenia. 
5.3 IMPLICATION IN WORKING MEMORY MATURATION AND 
SCHIZOPHRENIA 
The cellular basis of working memory within DLPFC circuitry was identified from the 
studies on spatial working memory performance using in vivo electrophysiology in rhesus 
monkeys (Goldman-Rakic, 1995). In these studies, a monkey was subjected to the oculomotor 
delayed response (ODR) task in which the animal was trained to briefly view a spatial cue and 
then remember the position over a delay period of several seconds. At the end of the delay 
period, the monkey could make a hand or eye movement to the remembered direction. In vivo 
recordings demonstrated that the DLPFC activity during the delay period of this task was 
predominantly generated by the excitation of L3D pyramidal neurons (Kritzer and Goldman-
Rakic, 1995). Thus, these neurons were thought to represent and maintain the information about 
visual space in the absence of sensory stimulation. Importantly, clusters of neighboring L3D 
pyramidal neurons within a micro-column were spatially tuned together, firing together across 
the delay period when the direction of stimulus coincides with the neurons’ preferred direction 
(Funahashi et al., 1989).  
Subsequent studies have shown that fast-spiking (FS) interneurons also possessed 
spatially tuned delay activity similar to that of L3D pyramidal neurons (Rao et al., 1999, 2000). 
Interestingly, connected pairs of a L3D pyramidal neuron and an adjacent FS interneuron were 
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isodirectionally tuned, suggesting that a network of pyramidal cells and interneurons could be 
clustered based on their propensity to respond to certain spatial stimuli. If such a clustering exists 
for the neuronal network of pyramidal neurons and PV interneurons, it would facilitate the 
effective generation of gamma oscillations towards a specific stimulus without incorporating out-
of-tune signals from other neurons, thus establishing an anatomical organization for spatial 
memory fields similar to the receptive fields found in motor and sensory cortices.  
ErbB4 splicing shifts and synaptic pruning could provide a mechanism that contributes 
to establishing the spatial tuning of PV interneurons that is coherent with that of nearby cluster of 
pyramidal neurons (Figure 18A). In this model, a cluster of L3D pyramidal neurons tuned to 90-
degree angle make excitatory projections to local PV interneurons. These PV neurons initially 
receive additional inputs from pyramidal neurons that are tuned to zero-degree angle and thus 
fail to achieve isodirectional tuning with either clusters of pyramidal neurons. During postnatal 
development, recurring recruitment of PV interneurons from the 90 degree-tuned L3D pyramidal 
neurons results in an activity-dependent stabilization and maturation of synaptic connections 
between these two neuronal populations. Increasing activity of PV interneurons triggers 
developmental shifts in ErbB4 splicing from the JM-b/CYT-2 to JM-a/CYT-1 variants in these 
neurons, which induces pruning of weak and immature excitatory synaptic inputs from the zero 
degree-tuned pyramidal neurons. These processes would collectively result in increases in the 
strength and the precision of PV interneuron recruitment by the spatially-tuned pyramidal neuron 
cluster. As the effective recruitment of PV interneurons is critical for generating cortical gamma 
oscillations (Jonas et al., 2004), this model may provide a circuit-based mechanism for the 
maturation of gamma oscillations during adolescence in primate DLPFC (Cho et al., 2015). 
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In schizophrenia, perhaps the loss of dendritic spines in the 90 degree-tuned pyramidal 
neurons might reduce PV interneuron activity, which would trigger abnormal shifts in ErbB4 
splicing and an exaggerated pruning process that eliminates the excitatory inputs from the 90 
degree-tuned L3D pyramidal neurons. This exaggerated pruning process would result in a further 
reduction of PV neuron activity and consequently lower feedback inhibition to hypoactive 90 
degree-tuned L3D pyramidal neurons. However, reduction in the strength of excitatory drive to 
PV neurons would impair the proper recruitment of PV neurons by the 90 degree-tuned L3D 
pyramidal neurons, and consequently would result in deficient cortical gamma oscillations and 
working memory dysfunction in schizophrenia. Collectively, the degree of effective PV 
interneuron recruitment would form an inverted U-shaped curve as a function of ErbB4 splicing 
shifts (Figure 18B). Intriguingly, animal models that recapitulate the abnormal loss or gain of 
ErbB4 signaling both exhibit synaptic dysfunction and behavioral deficits (Marin and Rico, 
2013; Yin et al., 2013b; Agarwal et al., 2014). These observations led to the hypothesis that there 
is an optimal range for ErbB4 signaling in the brain and either too much or too little ErbB4 
signaling is sufficient to impair neuronal development and synaptic plasticity (Figure 18C) (Mei 
and Nave, 2014). Therefore, our model suggests that maintaining the optimal range of ErbB4 
splicing shifts and pruning of excitatory inputs to PV neurons in the DLPFC could serve as 
molecular and synaptic substrates for the inverted U-shaped effect of NRG-1/ErbB4 signaling 
pathway on working memory performance and potentially other cognitive function. In section 
5.4 I will discuss potential experiments that could at least partly test the validity of this model. 
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Figure 18. Proposed role of ErbB4 splicing shifts and pruning of excitatory inputs to PV interneurons in 
working memory maturation and schizophrenia 
(A) Simplified DLPFC microcircuitry depicting L3D pyramidal neurons (blue) that maintain persistent firing across 
the delay period for the neuron’s preferred direction (either 90˚ or 0˚) and PV interneuron (yellow) that receives 
excitatory inputs from L3D pyramidal neurons. Under-pruning: Prior to adolescence, PV neuron receives excitatory 
inputs from both 90˚ and 0˚ preferred L3D neurons and therefore this PV neuron can be recruited by both 
populations of L3D neurons. Isodirectionally tuned: During adolescence, maturation of synaptic connection between 
PV neuron and 90˚ preferred L3D neurons triggers shifts in ErbB4 splicing and pruning of excitatory inputs from 0˚ 
preferred L3D neurons. Consequently, this PV neuron is recruited selectively by 90˚ preferred L3D neurons. Over-
pruning: In schizophrenia, an exaggerated pruning process eliminates synaptic connections between PV neuron and 
90˚ preferred L3D neurons and therefore this PV neuron is recruited weakly by 90˚ preferred L3D neurons. (B) 
Collectively, the recruitment of PV neuron by 90˚ preferred L3D neurons would be less efficient prior to 
adolescence and in schizophrenia, due to the lack of precision or strength, respectively, in excitatory drive to PV 
neuron. (C) As efficient PV neuron recruitment is critical for generating cortical gamma oscillations and working 
memory performance, ErbB4 splicing shifts and pruning of excitatory inputs to PV neurons may contribute to the 
proposed inverted-U shaped effect of ErbB4 signaling on cognitive function. Figure 4C is adapted from Mei L, Nave 
KA (2014) Neuron 83:27-49. 
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5.4 CONCLUDING REMARKS: FUTURE STUDIES 
In this general discussion section, I have postulated potential role of ErbB4 splicing 
shifts and pruning of excitatory inputs to PV interneurons in maintaining E/I balance of cortical 
circuitry, working memory maturation and schizophrenia. First, I proposed that alternative 
splicing of ErbB4 could be regulated in an activity-dependent manner, allowing PV interneurons 
to regulate the excitatory input number they receive in response to changes in neuronal activity. 
Second, I proposed that dendritic spine plasticity might trigger ErbB4 splicing shifts in PV 
interneurons and pruning of excitatory inputs to these neurons in order to restore E/I balance in 
development and schizophrenia. Third, I proposed that ErbB4 splicing shifts and pruning of 
excitatory inputs to PV neurons could provide molecular and synaptic substrates for the inverted 
U-shaped effect of NRG-1/ErbB4 signaling pathway on working memory function. I would like 
to conclude my dissertation by providing three aims and sets of hypotheses for each aim that 
could test, at least partly, the validity of those models that are proposed in the discussion 
sections.  
In the first aim, I propose that alternative splicing of ErbB4 transcripts in PV 
interneurons is regulated in an activity-dependent manner. In order to investigate this aim, I 
propose the following sets of hypotheses that can be tested in rat cortex and primary neuronal 
culture, similar to the previous study that investigated the effect of neuronal activity on 
alternative splicing of neuregulin-1 transcripts (Liu et al., 2011). First, I hypothesize that the four 
ErbB4 splice variants (JM-a, JM-b, CYT-1, CYT-2) are expressed in adult rat cortex and the 
relative ratios of minor to major variants are similar to those found in the primate DLPFC. 
Second, I hypothesize that ErbB4 splicing shift occurs during postnatal development and 
parallels with the developmental trajectory of PV expression in rat cortex (de Lecea et al., 1995). 
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Third, I hypothesize that in primary rat neuronal culture, shifts in ErbB4 splicing from the JM-
b/CYT-2 to JM-a/CYT-1 variants occur in response to increasing concentrations of kainic acid 
until it reaches a plateau; the ErbB4 splicing shifts would be abolished with an overexpression of 
MIAT if MIAT indeed does regulate ErbB4 splicing. Finally, I hypothesize that with increasing 
incubation period with kainic acid, the slope of ErbB4 shifts is greater for the lower 
concentration than the higher concentration of kainic acid. The results from this study would 
elucidate whether 1) shifts in ErbB4 splicing is a conserved mechanism across developing brains 
of different species, 2) an activity-dependent mechanism is involved in modulating ErbB4 
splicing, and 3) ErbB4 splicing shift could be differentially regulated by moderate (arrested) and 
high neuronal activity. 
In the second aim, I propose that dendritic spine maturation precedes the maturation of 
excitatory inputs to PV neurons and deficits in spine maturation induce an over-pruning of 
excitatory inputs to PV neurons. In order to validate this aim, I propose the following sets of 
hypotheses that can be tested using a developmental monkey cohort expanded from chapter 4 
and an existing Arp 2/3 knock out (KO) mouse model in which dendritic spine formation is 
impaired (Kim et al., 2015). First, I hypothesize that the onset of L3D dendritic spine pruning 
precedes the pruning onset of excitatory synaptic inputs to PV interneurons during postnatal 
development in monkey DLPFC. Second, I hypothesize that ErbB4 splicing is shifted from the 
JM-b/CYT-2 to JM-a/CYT-1 variants in the Arp 2/3 KO mouse compared to the wild type 
mouse. Third, I hypothesize that the density of VGlut1+/PSD95+ puncta on PV+ neurons is 
lower in the Arp 2/3 KO mouse compared to the wild type mouse. Finally, I hypothesize that 
inhibitory transmission is reduced in pyramidal neurons of the Arp 2/3 KO mouse compared to 
the wild type mouse. The results from this study would elucidate whether 1) the maturation onset 
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of dendritic spines and excitatory inputs to PV neuron coincides or differs, 2) the deficits in 
dendritic spine maturation could provide an upstream cause for dysregulated ErbB4 splicing 
shifts and the loss of excitatory inputs to PV neurons and 3) these downstream processes could 
contribute to reduced feedback inhibition to hypoactive pyramidal neurons. 
Finally, in the third aim, I propose that the ErbB4 splicing shifts and pruning of 
excitatory synaptic inputs to PV neurons contribute to the inverted U-shaped effect of NRG-
1/ErbB4 signaling on cognitive function. In order to validate this aim, I propose the following 
sets of hypotheses that can be tested by using an existing mouse model in which NRG-1 is 
overexpressed in order to induce an abnormally high level of ErbB4 activation (ctoNrg1 mouse) 
(Yin et al., 2013b). I first hypothesize that in ctoNrg1 mouse, PV interneurons receive a greater 
number of excitatory synaptic inputs then those in control mouse. Second, I hypothesize that 
reducing Nrg1 to normal levels results in pruning of excitatory synaptic inputs to PV 
interneurons. Third, I hypothesize that shifts in ErbB4 splicing accompany those changes in the 
density of excitatory synapses on PV interneurons. The results from this study would elucidate 
whether 1) the gain of ErbB4 signaling is associated with an under-pruning of excitatory inputs 
to PV neurons, 2) the under-pruning of excitatory inputs to PV neurons could contribute to 
cognitive dysfunction and 3) ErbB4 splicing shifts could provide underlying mechanisms to 
these processes. 
The ultimate goal of schizophrenia research is to develop more effective treatments and 
preventative measures for patients with this illness, which requires greater knowledge of the 
underlying disease process. In order to understand the disease process of schizophrenia, it is 
critical to identify an abnormality in the brain that is associated with the clinical syndrome 
(pathology), investigate pathogenic mechanisms underlying this pathology (pathogenesis) and 
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understand how such pathology can give rise to alterations in brain function (pathophysiology) 
(Lewis et al., 2005). Rational therapeutic strategy then can be developed that either interrupts or 
reverses the pathophysiological processes and pathogenetic mechanisms, respectively (Lewis and 
Sweet, 2009). In this dissertation, I have identified fewer excitatory inputs to PV interneurons as 
a novel pathology of schizophrenia, implicated developmental disturbances in ErbB4 splicing 
shifts and pruning of excitatory inputs to PV neurons as the underlying pathogenic mechanisms 
and speculated the potential role of these processes in the emergence of the pathophysiological 
element that is associated with the core clinical feature of schizophrenia. Therefore, further 
elucidating the role of abnormal ErbB4 splicing shifts and an exaggerated pruning of excitatory 
inputs to PV neurons in schizophrenia, and investigating how these processes can be interrupted 
or reversed along the course of illness, may provide critical insights for development of new 
therapeutic interventions for individuals with schizophrenia. 
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APPENDIX A 
TABLE 3. DEMOGRAPHIC, POSTMORTEM, AND CLINICAL CHARACTERISTICS 
OF HUMAN SUBJECTS USED IN THIS DISSERTATION. 
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*: Subject pairs used for layer-specific qPCR; #: Subject pairs used for microarray; +: Subject pairs used for immunohistochemistry a: 
C, normal comparison; S, schizophrenia; b: A, age in years; B, black; F, female; M, male; R, race; S, sex; W, white; c: PMI, 
postmortem interval (hours); d: Storage time (months) at -80C; e: ASCVD, arteriosclerotic cardiovascular disease; MCA, middle 
coronary artery; f: DS, disorganized schizophrenia; PS, paranoid schizophrenia; SA, schizoaffective disorder; US, undifferentiated 
schizophrenia; g: ADC, alcohol dependence, current at time of death; ADR, alcohol dependence, in remission at time of death; AAC, 
alcohol abuse, current at time of death; AAR, alcohol abuse, in remission at time of death; ODC, other substance dependence, current 
at time of death; ODR, other substance dependence, in remission at time of death; OAC, other substance abuse, current at time of 
death; OAR, other substance abuse, in remission at time of death; h: BZ/VPA ATOD; BZ, benzodiazepines; VPA, Sodium valproate; 
ATOD, at time of death; Y, yes; N, no. 
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APPENDIX B 
SUPPLEMENTAL INFORMATION FOR DYSREGULATED ERBB4 SPLICING IN 
SCHIZOPHRENIA: SELECTIVE EFFECTS ON PARVALBUMIN EXPRESSION 
B.1 SUPPLEMENTARY METHODS 
Total gray matter RNA extraction 
The gray-white matter boundary of DLPFC area 9 in a tissue block from each subject was 
carefully scored with a scalpel blade where the gray matter had uniform thickness and the gray-
white matter boundary was easily delineated. The scored gray matter region of the tissue block 
was then digitally photographed, and the number of tissue sections (40 µm) required to collect 
~30 mm3 of gray matter was determined for each subject. The calculated number of required 
tissue sections for each subject was then cut by cryostat, and gray matter was separately collected 
into a tube containing TRIzol reagent in a manner that ensured minimal white matter 
contamination and excellent RNA preservation. Complementary DNA (cDNA) was synthesized 
from standardized dilutions of total RNA (10 ng/μl) for each subject.  
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Microarray analysis 
For laser microdissection of individual neurons, cryostat sections of DLPFC area 9 were 
dual-labeled with lectin Vicia villosa agglutinin (VVA) and anti-NeuN antibody in order to 
visualize parvalbumin interneuron-selective perineuronal nets and all neurons, respectively. 
RNA was extracted from pooled samples of 360 VVA-labeled neurons, converted into cDNA, 
amplified, labeled with biotin, and loaded on Affymetrix GeneChip HT HG-U133+ PM Array 
Plate (Affymetrix, Santa Clara, CA). Scanned images were segmented and converted into DAT 
files, using Microarray Analysis Suite 5.0. Segmented images were normalized and log2-
transformed using GeneChip Robust Multiarray Average (Georgiev et al., 2014). 
 
Genotype analysis 
DNA was isolated from brain tissue using standard techniques and genotyped by the 
Illumina Infinium HumanOmniExpressExome array (Illumina, INC, San Diego, CA). Genotype 
calls were retained if they passed quality control for samples and SNPs, which yielded 767,368 
SNPs for all samples. To impute a larger set of genotypes per sample, haplotypes were inferred 
and variants were imputed in 5Mb segments by Impute v2.3.1 (Howie et al., 2009) with the 1000 
Genomes Phase 1 integrated reference panel (Genomes Project et al., 2010). Of the 4 SNPs 
evaluated in this study, 3 were genotyped directly and one was imputed (rs4673628). Due to 
missing genotype information, some subjects were excluded from the analyses.  
 
Statistical analysis 
Repeated measures model was implemented in SAS PROC MIXED using the REML 
method in order to analyze layer-specific expression of PV, CR and ErbB4 splicing variants. In 
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the REML method, the Kenward-Roger degrees of freedom approximation method was used to 
compute the denominator degrees of freedom (Kenward and Roger, 1997). Paired and unpaired 
repeated measures models included mRNA level as the dependent variable; diagnosis, cortical 
layer, and the interaction between diagnosis and cortical level as main effects. Covariates were 
included in each model as described for the ANCOVA model. 
The potential influence of co-morbid factors (e.g., diagnosis of schizoaffective disorder; 
history of substance dependence or abuse; nicotine use at time of death; antipsychotic, 
antidepressant or benzodiazepine and/or sodium valproate use at time of death; or death by 
suicide) on the levels of JM-a, JM-b, CYT-1 and CYT-2 mRNAs in layer 4 of schizophrenia 
subjects were assessed by using an ANCOVA model with each factor as the main effect and sex, 
age, brain pH, RIN, PMI, storage time as covariates.  
Relationships between the ratios of minor to major ErbB4 splicing variants and CR or PV 
mRNA levels in layers 2 or 4, respectively, were assessed by Pearson’s correlation analysis with 
the Bonferroni-corrected alpha level of 0.006 (Curtin and Schulz, 1998). 
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B.2 SUPPLEMENTARY TABLES 
Table 4. Oligonucleotide sequences of forward and reverse primers for ErbB4 splicing variants, pan-ErbB4 and MIAT. 
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Table 5. Summary statistics comparing the levels of transcripts between subject groups in total gray matter, layer 2 or 4 by paired ANCOVA or 
paired repeated measures models. 
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Table 6. Relationship between the ratios of ErbB4 splicing variants and the levels of CR or PV mRNA and in layer 2 or 4, respectively. 
Table 7. Summary statistics displaying the main effect of genotypes and interactions between genotypes and diagnosis on the ratios of JM-a/JM-b 
variants or CYT-1/CYT-2 variants. 
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B.3 SUPPLEMENTARY FIGURES 
 
 
Figure 19. Specificity of qPCR primers for calretinin, parvalbumin, ErbB4 splice variants and pan-ErbB4. 
Gel electrophoresis displaying the post-qPCR amplicon products for calretinin, parvalbumin, ErbB4 splicing 
variants and Pan-ErbB4 transcripts. + : qPCR with cDNA. - : qPCR without cDNA. Ladder : GeneRuler Low Range 
DNA Ladder, Life Technologies Cat#SM1193. 
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Figure 20. qPCR amplicon products blasted to specific ErbB4 splice variants. 
Results of UCSC In-Silico PCR blast (https://genome.ucsc.edu/cgi-bin/hgPcr) for each primer pair targeting ErbB4 
splicing variants in relation to the alternative exons of ErbB4 transcripts. Note that the primer pair targeting CYT-1 
variant includes exon 26, whereas the pair targeting CYT-2 variant excludes it. The exon 16 or 15b is selectively 
spanned for the primer pair targeting JM-a or JM-b variants, respectively. 
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Figure 21. No effect of co-morbid factors on the normalized ErbB4 splice variant levels in subjects with 
schizophrenia. 
In each pair of plots, schizophrenia subjects are grouped by potential confounding factors listed on the x-axis. 
Circles represent the levels of ErbB4 splicing variants for individual subjects and the bars represent mean ErbB4 
splicing variant levels for the indicated group. Numbers listed for each bar represent the number of schizophrenia 
subjects for each condition. Levels of CYT-1 (A), CYT-2 (B), JM-a (C) and JM-b (D) in layers 4 of schizophrenia 
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subjects did not differ significantly (all F values <5.4, all p-values > 0.182) as a function of sex, diagnosis of 
schizoaffective disorder, history of substance dependence or abuse, nicotine use at the time of death, use of 
antipsychotics, antidepressants, or benzodiazepines and/or sodium valproate at the time of death, or death by suicide 
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APPENDIX C 
SUPPLEMENTAL INFORMATION FOR PATHOLOGICAL BASIS FOR DEFICIENT 
EXCITATORY DRIVE TO CORTICAL PARVALBUMIN INTERNEURONS IN 
SCHIZOPHRENIA 
C.1 SUPPLEMENTARY METHODS 
Antibody Characterization  
The mouse anti-PV antibody (Cat#235, Lot#10-11F, Swant) recognized a single band at 
the expected size of 12 kDa by western blotting and showed an absence of immunoreactivity by 
immunohistochemistry in PV knockout mice(Celio et al., 1988; Schwaller et al., 1999). The goat 
anti-CR antibody (Cat#CG1, Lot#1ξ1, Swant) showed an absence of immunoreactivity by 
immunohistochemistry in CR knock-out mice(Schiffmann et al., 1999). The guinea pig anti-
VGlut1 antibody (Cat#AB5905, Lot#22430498, Millipore) recognized a single band at the 
expected size of 60 kDa by western blotting(Melone et al., 2005) and preadsorption with the 
immunogen peptide abolished immunolabeling (reported by the manufacturer). The rabbit anti-
PSD-95 antibody (Cat#3450s, Lot#2, Cell Signaling) recognized a single band of 95 kDa on 
western blots from extracts of rat brain and human cerebellum as reported by the manufacturer, 
and highly co-localized with immunolabeling of a well-characterized mouse monoclonal anti-
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PSD-95 antibody (Neuromab cat. no. 75-028)(Soiza-Reilly and Commons, 2011). All secondary 
and tertiary antibodies used in this study were shown to produce minimum cross-reactivity by the 
manufacturers. 
 
PMI effect on protein immunoreactivity 
Because PMI may affect protein immunoreactivity(Lewis, 2002), we assessed the density 
of VGlut1+/PSD95+ puncta onto PV+ cell bodies in 6 control subjects with PMIs ranging from 
4.8 to 22.7 hours. The density of Vglut1+/PSD95+ puncta onto PV+ cell bodies was not 
correlated with PMI in these subjects (R=-0.111, p=0.835), suggesting that the detectability of 
excitatory inputs is not influenced by a PMI less than 24 hours. 
  
Antibody Penetration Efficiency Analysis 
To check for penetration efficiency of anti-VGlut1 or anti-PSD95 antibody, we 
preliminarily assessed the distribution of VGlut1+ or PSD95+ masks along the Z-axis in ten 
random image stacks from control subjects. Z-axis per each image was divided into 10 bins, with 
each bin representing the 10% of total Z-axis from the top (100%) to the bottom (1%) of the 
section. Mean percent localization of VGlut1+ or PSD95+ masks in 1~10% and 91~100% of the 
Z-axis were significantly different from those in the middle 80% of the Z-axis (VGlut1: 
F9,90=9.5,p<0.001; PSD95: F9,90=20.9,p<0.001; post hoc tukey’s test p<0.05). Therefore, only the 
objects localized within the 80% of middle z-planes (~32 μm) were sampled for data analysis.  
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VGlut+ and PSD95+ puncta segmentation 
First, a custom channel was made for each deconvolved channel of VGlut1 or PSD95 by 
calculating a difference of Gaussians using sigma values of 0.7 and 2. Then, the Ridler-Calvard 
threshold value was applied to the fluorescence intensity histogram of either VGlut1+ or 
PSD95+ labeling and all pixels were reassigned to a binary value according to whether they were 
above or below the threshold value, and the resulting binary image was referred to as the object 
mask. Then these object masks were automatically defined as VGlut1+ or PSD95+ masks if they 
fell in the range of defined puncta size (0.06-0.7µm3)(Fish et al., 2008).  Choosing a single 
threshold value may not be sufficient to ensure comprehensive masking of VGlut1+ and PSD95+ 
puncta, as protein levels differ within synaptic structures and vary substantially as a result of 
disease states. Therefore, we utilized the MATLAB script, which performs multiple iterations of 
automated masking process that starts from the Ridler-Calvard threshold value and incrementally 
migrates towards the highest intensity value. The resulting object masks from each iteration were 
combined to represent the total population of VGlut1+ or PSD95+ puncta. Lipofuscin 
autofluorescence labeling was masked using the Ridler-Calvard threshold value as explained 
above and was subtracted from the VGlut1+ or PSD95+ masks for final analysis. 
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C.2 SUPPLEMENTARY FIGURES 
 
Figure 22. Representative raw, deconvolved and masked images of PV+ cell bodies, CR+ cell bodies, VGlut1+ puncta, PSD95+ puncta and lipofuscin in 
human DLPFC. 
PV+ neurons with varying intensity range (white arrow – PV mean intensity: 2810 a.u., PV sum intensity: 133426234 a.u.; gray arrow –  PV mean intensity: 951 
a.u., PV sum intensity: 35779294 a.u.) and CR+ neurons with varying intensity range (white arrow – CR mean intensity: 3189 a.u., CR sum intensity: 50431392 
a.u.; gray arrow – CR mean intensity: 1010 a.u., CR sum intensity: 7999625 a.u.) were masked as described in Methods. Lipofuscin masks (white arrowheads) 
were subtracted from the puncta mask for final analyses. Scale bar = 10μm. 
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Figure 23. Levels of VGlut1 or PSD95 immunoreactivity within VGlut1+ puncta or PSD95+ puncta, respectively, onto PV interneurons are unaltered in 
schizophrenia subjects. 
X denotes a subject pair identified as an outlier by the Grubbs’ test (Z=3.38, p<0.01). Statistical analyses with and without the outlier pair are shown. 
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Figure 24. No effect of co-morbid factors on the mean density of VGlut1+/PSD95+ puncta onto PV+ cell bodies in subjects with schizophrenia. 
In each pair of plots, schizophrenia subjects are grouped by the co-morbid factors listed on the x-axis. Circles represent the levels of the mean density for 
individual schizophrenia subjects and the bars represent mean density for the indicated group. Numbers listed for each bar represent the number of schizophrenia 
subjects with that condition. Mean density of VGlut1+/PSD95+ puncta onto PV+ cell bodies in schizophrenia subjects did not differ significantly as a function of 
diagnosis of schizoaffective disorder, history of substance dependence or abuse, nicotine use at the time of death, use of antidepressants, or benzodiazepines 
and/or sodium valproate at the time of death, or death by suicide.  
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Figure 25. Density of excitatory synaptic inputs to PV interneurons is not altered in monkeys treated with psychotropic medications. 
(A-D) Mean numbers of sampled PV+ neurons, mean PV immunoreactivity levels in PV+ cell bodies, mean surface area of PV+ cell bodies or mean density of 
VGlut1+/PSD95+ puncta onto PV+ cell bodies was not altered in the monkeys treated with haloperidol or olanzapine compared to the monkeys treated with 
placebo. 
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APPENDIX D 
SUPPLEMENTAL INFORMATION FOR DEVELOPMENTAL PRUNING OF 
EXCITATORY INPUTS TO PARVALBUMIN INTERNEURONS IN MONKEY 
PREFRONTAL CORTEX: CONTRIBUTION OF ERBB4 SPLICING 
D.1 SUPPLEMENTARY METHOD 
In situ hybridization.  
Cryostat sections (20 µm) containing right DLPFC area 46 were mounted onto glass 
slides from a subset of monkeys (5 pre-pubertal and 3 post-pubertal) due to limitations in tissue 
availability. Sections were fixed with 4% paraformaldehyde in PBS and then acetylated with 
0.25% acetic anhydrate in 0.1 M triethanolamine/0.9% NaCl for 10 minutes, dehydrated through 
a graded ethanol series, and defatted in chloroform for 10 minutes. The sections were then 
hybridized with 35S-labeled riboprobes (2 × 107 dpm/ml) targeting bases 59-403 of PV mRNA 
in hybridization buffer containing 50% formamide, 0.75 M NaCl, 20 mM 1,4-piperazine 
diethane sulfonic acid, pH 6.8, 10 mM EDTA, 10% dextran sulfate, 5X Denhardt's solution (0.2 
mg/ml Ficoll, 0.2 mg/ml polyvinylpyrrolidone, 0.2 mg/ml BSA), 50 mM dithiothreitol, 0.2% 
SDS, and 100 μg/ml yeast tRNA at 56°C for 16 hours. The sections were then washed in a 
solution containing 0.3 M NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0, and 50% 
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formamide at 63°C, treated with RNase A (20 μg/ml) at 37°C, and washed in 0.1× SSC (150 mM 
NaCl, 15 mM sodium citrate) at 67°C. Finally, sections were dehydrated through a graded 
ethanol series, air dried, and exposed to BioMax MR film (Kodak, Rochester, NY) for 72 hours. 
Film optical density (OD) was quantified as nanocuries per gram of tissue by reference to 
radioactive C-14 standards. PV mRNA expression as a function of cortical layer was quantified 
in approximately 1-mm-wide cortical traverses extending from the pial surface to the white 
matter. Each traverse was divided into 50 equal bins parallel to the pial surface and the OD was 
determined for each bin. 
 
Masking of VGlut1+ and PSD95+ puncta and PV cell body.  
For the purpose of masking synaptic structures, a custom channel was made for each 
deconvolved channel of VGlut1 or PSD95 by calculating a difference of Gaussians using sigma 
values of 0.7 and 2. The Ridler-Calvard threshold value was applied to the fluorescence intensity 
histogram of either VGlut1+ or PSD95+ labeling and all pixels were reassigned to a binary value 
according to whether they were above or below the threshold value, and the resulting binary 
image was referred to as the object mask. These object masks were automatically defined as 
VGlut1+ or PSD95+ masks if they fell in the range of defined puncta size (0.06-0.7µm3). 
Multiple iteration of binary masking process was then performed with the threshold level 
incrementally increasing for each iteration of masking until it reached the highest intensity value. 
The resulting object masks from each iteration were combined to represent the total population 
of VGlut1+ or PSD95+ puncta. Edges of PV cell bodies were segmented by the MATLAB edge 
function using the Canny edge detector operator. The edges of segmented objects were closed, 
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filled, and size-gated (>80 µm3) to limit the boundaries of PV cell bodies. All PV cell body 
masks were manually cleaned for final analyses. 
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